Gallstone disease (GSD) is one of the most common human diseases. Among diseases of the digestive system, it occupies a leading place, while not only gastroenterologists and therapists, but also doctors of other specialties, including surgeons, participate in its treatment.

Epidemiological studies of the incidence of cholelithiasis indicate that the number of patients in the world at least doubles every decade. In general, in Europe and other regions of the world, cholelithiasis is detected in 10-40% of the population of various ages. In our country, the incidence of this disease ranges from 5% to 20%. In the north-west of Russia, gallstones (GB) are detected on average in every fifth woman and every tenth man. The significant prevalence of this pathology is associated with the presence of a large number of risk factors that have become relevant in recent times. The most important of these include hereditary predisposition, anomalies in the development of the biliary tract, inadequate nutrition, the use of medicines(oral contraceptives, drugs to normalize lipid metabolism, ceftriaxone, sandostatin derivatives, nicotinic acid), manifestations of the metabolic syndrome (obesity, diabetes, dyslipoproteinemia), pregnancy, inflammatory bowel disease, chronic constipation, physical inactivity and others.

It should be noted that the pathogenesis of stone formation is still being studied, however, it is known that a violation of the mechanisms of enterohepatic circulation (EHC) of cholesterol and bile acids is of key importance. The causes of violation of the EHC are:

• violation of the rheology of bile (oversaturation of it with cholesterol with increased nucleation and the formation of crystals);
• violation of the outflow of bile associated with a change in the motility and patency of the gallbladder, small intestine, sphincter of Oddi, sphincters of the common pancreatic and bile ducts, combined with a change in the peristalsis of the intestinal wall;
• violation of intestinal microbiocenosis, since with a change in the composition and a decrease in the amount of bile in the intestinal lumen, the bactericidal activity of the duodenal contents changes with excessive reproduction of bacteria in the ileum, followed by early deconjugation of bile acids and the formation of duodenal hypertension;
• indigestion and absorption, since against the background of duodenal hypertension and increased intraluminal pressure in the ducts, damage to the pancreas occurs, with a decrease in the outflow of pancreatic lipase, which disrupts the mechanisms of emulsification of fats and activation of the pancreatic enzyme chain, creating prerequisites for biliary pancreatitis.

An important unfavorable prognostic factor for cholelithiasis is the development of serious complications that affect the course of the disease. These include acute cholecystitis, choledocholithiasis, obstructive jaundice, cholangitis, and chronic pancreatitis (CP). In addition, inadequately chosen tactics for treating a patient with cholelithiasis often leads to the development of postoperative complications, the so-called postcholecystectomy syndrome, which significantly worsens the quality of life of these patients. The main reason for these circumstances is the lack of compliance between therapists and surgeons, while the former do not have a clear strategy for managing patients with cholelithiasis, and the latter are interested in a wide surgical treatment of all patients of this profile.

Despite the long history of this disease, the only generally accepted classification tool remains the three-stage subdivision of cholelithiasis into 1) physicochemical stage, 2) asymptomatic lithiasis, and 3) stage of clinical symptoms and complications.

This classification, developed with the direct participation of surgeons, however, does not answer a whole list of practical questions that a therapist has when treating patients of this profile, for example:

• should it be carried out drug treatment cholelithiasis; if such a need exists, then with what drugs and in the conditions of the department of which profile;
• what are the criteria for the effectiveness and ineffectiveness of drug therapy;
• what are the indications for a particular patient for surgical treatment;
• whether the patient should be observed after the operation, by which specialist, for how long and with what drugs to carry out postoperative treatment.

That is, to date, the generally accepted tactics for monitoring patients with cholelithiasis has not been developed.

As evidenced by the analysis of the literature, the only algorithm for managing patients with this pathology is the international Euricterus recommendations for the selection of patients with cholelithiasis for surgical treatment, adopted at the congress of surgeons in 1997 (Table 1).

Of the presented in table. It follows from Table 1 that there are a large number of patients with cholelithiasis for whom surgical treatment is not indicated, but neither diagnostic nor therapeutic tactics have been determined for them. Therefore, a detailed selection of clinical diagnostic criteria that would allow subdividing all patients with this pathology into groups may be significant for specialists.

For this, the most important are the factors used in the Euricterus system to make a decision to conduct surgical treatment. These include:

• the presence of clinical symptoms (syndrome of the right hypochondrium or biliary pain, biliary colic);
• the presence of concomitant HP;
• reduced contractile function of the gallbladder;
• presence of complications.

Evaluation of the features of clinical symptoms in patients with cholelithiasis requires differential diagnosis between the syndrome of the right hypochondrium, due to functional biliary disorder (FBI), and biliary (hepatic) colic, which often causes difficulties even for qualified specialists. At the same time, a correct assessment of the clinical picture and, in particular, taking into account the number of colic in the anamnesis largely determine the tactics of managing a patient with cholelithiasis, followed by the choice of direction for conservative therapy, sphincteropapillotomy or cholecystectomy.

It should be noted that these clinical phenomena have fundamentally different mechanisms, so in FBI, pain is a consequence of a violation of the contractile function (spasm or stretching) of the sphincter of Oddi or the muscles of the gallbladder, which prevents the normal outflow of bile and pancreatic secretions into the duodenum. Whereas with biliary colic, it occurs due to mechanical irritation of the gallbladder wall by the stone, obstruction of the gallbladder, wedging into the neck of the gallbladder, into the common bile, hepatic or cystic duct. However, it should be emphasized that part of the pain in colic is due to the FBI. For differential diagnosis, the authors proposed to take into account the main clinical signs, presented in Table. 2.

Having thus assessed the clinical picture of patients with cholelithiasis, their subsequent division into groups is possible.

The 1st group of patients with cholelithiasis should include patients without active complaints and obvious clinical symptoms. Diagnostic criteria in this case will be the absence of biliary pain, the presence of biliary sludge (clots), detected by ultrasound.

The 2nd group includes patients with biliary pain (in the epigastric region and / or in the right hypochondrium, characteristic of a functional biliary disorder, and dyspeptic manifestations. The diagnostic criteria in this case are the presence of biliary / pancreatic pain, the absence of biliary colic, the presence of biliary sludge or stones on ultrasound.Rarely, there may also be a transient increase in transaminase and amylase activity associated with an attack.

Patients with cholelithiasis and symptoms of chronic pancreatitis deserve special attention, which, due to clinical, prognostic and, most importantly, therapeutic features, make up the 3rd group. Diagnostic criteria in this category of patients include: the presence of pancreatic pain, the absence of biliary colic, the presence of signs of pancreatitis, stones and / or biliary sludge in beam methods studies (ultrasound, CT, MRI), an increase in the activity of lipase, amylase, a decrease in elastase-1 and the presence of steatorrhea are possible.

Patients with gallstone disease with symptoms of one or more attacks of biliary colic, belonging to the 4th group, are already patients with surgical pathology. Diagnostic criteria in this case are: the presence of one or more biliary colic, gallstones, possible transient jaundice, increased activity of ALT, AST, GGTP, bilirubin levels associated with hepatic colic. It should be emphasized the need for a detailed identification of biliary colic in history, after the manifestation of which months and even years may pass.

After determining the clinical groups, the directions of therapy for patients with cholelithiasis are both general and individual, group-specific. General directions include approaches that improve EHC processes and suppress the mechanism of stone formation in the gallbladder. These approaches include:

1. impact on risk factors and recurrence factors;
2. improvement of the rheological properties of bile;
3. normalization of motility of the gallbladder, small intestine and restoration of the patency of the sphincter of Oddi, as well as the sphincters of the common pancreatic and bile ducts;
4. restoration of the normal composition of the intestinal microflora;
5. normalization of the processes of digestion and absorption with the restoration of the functioning of the pancreas.

Impact on risk factors and recurrence factors

A set of measures aimed at eliminating factors contributing to stone formation includes the abolition or correction of the dose of lithogenic drugs (estrogens, third-generation cephalosporins, drugs that affect the lipid spectrum, somatostatin, etc.), prevention of congestive biliary tract, including in pregnant women, treatment of biliary sludge, hormonal correction.

The diet in patients with cholelithiasis should be balanced in terms of the content of proteins (meat, fish, cottage cheese) and fats, mainly vegetable. So, the rational intake of protein and fat increases the cholate-cholesterol coefficient and reduces the lithogenicity of bile. The polyunsaturated fatty acids that are part of vegetable oils contribute to the normalization of cholesterol metabolism, the restoration of cell membranes, participate in the synthesis of prostaglandins and normalize the contractile function of the gallbladder. Prevention of excessive pH shift to the acid side by limiting flour and cereal products and prescribing dairy products (if they are tolerated) also reduces the risk of stone formation. High-calorie and cholesterol-rich foods are excluded. Compliance with the diet helps to reduce the likelihood of spastic contraction of the muscles of the stomach and the sphincter of Oddi, which can cause the migration of stones, including small ones (sand).

In the presence of a pronounced exacerbation of CP, in the first three days, the patient is prescribed complete hunger with the use of water. Subsequently, meals should be frequent, fractional, with the exception of fatty, fried, sour, spicy foods and contribute to the normalization of the patient's body weight.

Improving the rheological properties of bile

To date, the only pharmacological agent with a proven effect on bile rheology is ursodeoxycholic acid. Our own experience in the treatment of patients with cholelithiasis is associated with Ursosan. With regard to determining the indications for the use of ursodeoxycholic acid preparations in cholelithiasis, it is important to take into account the achievement of remission of pancreatitis and the absence of extrahepatic cholestasis. Therapy with this drug is carried out until the physicochemical and rheological properties of bile are normalized, the number of microliths in the bile is reduced, further stone formation is prevented and stones can be dissolved. Its additional immunomodulatory and hepatoprotective effects are also taken into account. Ursosan is prescribed at a dose of up to 15 mg/kg of body weight, the entire dose is taken once in the evening, an hour after dinner or at night. The duration of admission depends on the clinical situation, being approximately 6-12 months. In the presence of abdominal pain and dyspeptic syndromes, the dose should be titrated, starting with a minimum of 250 mg, one hour after dinner, for about 7-14 days, with a further increase of 250 mg at similar time intervals to the maximum effective. In this case, it is expedient to cover therapy, including the parallel use of a selective antispasmodic - Duspatalin (mebeverine).

Normalization of motility of the gallbladder, small intestine and restoration of the patency of the sphincter of Oddi, as well as the sphincters of the common pancreatic and bile ducts

The treatment allowance includes measures to correct the outflow from the ductal system of the pancreas and biliary tract using endoscopy (in the presence of organic changes - cicatricial stenosis of the sphincter of Oddi, calcifications and calculi in the ducts) and / or with the help of drugs. In this case, the means of conservative therapy are drugs that have an antispasmodic and eukinetic effect.

Commonly used non-selective antispasmodics (No-shpa, Papaverine) are drugs that do not have a dose-dependent effect, with low tropism for the biliary system and pancreatic ducts. The mechanism of action of these medicinal substances as a whole is reduced to inhibition of phosphodiesterase or activation of adenylate cyclase, blockade of adenosine receptors. Their disadvantages are significant differences in individual effectiveness, in addition, there is no selective effect on the sphincter of Oddi, there are undesirable effects due to effects on the smooth muscles of the vessels, urinary system, gastrointestinal tract.

Anticholinergics (Buscopan, Platifillin, Metatsin) also have an antispasmodic effect. Anticholinergic drugs that block muscarinic receptors on the postsynaptic membranes of target organs realize their action by blocking calcium channels, stopping the penetration of calcium ions into the cytoplasm of smooth muscle cells and, as a result, relieving muscle spasm. However, their effectiveness is relatively low, and a wide range of side effects (dry mouth, urinary retention, tachycardia, disturbance of accommodation, etc.) limit their use in this category of patients.

Separately in this series is an antispasmodic with a normalizing effect on the tone of the sphincter of Oddi - Duspatalin (mebeverine). The drug has a dual, eukinetic mechanism of action: a decrease in the permeability of smooth muscle cells to Na +, which causes an antispastic effect and the prevention of hypotension by reducing the outflow of K + from the cell. At the same time, Duspatalin has a tropism for the smooth muscles of the ducts of the pancreas and intestines. It eliminates functional duodenostasis, hyperperistalsis, without causing hypotension and without affecting the cholinergic system. The drug is usually prescribed 2 times a day 20 minutes before meals, at a dose of 400 mg / day, for up to 8 weeks.

Restoration of the normal composition of the intestinal microflora

An important section in the treatment of gallstone disease is antibacterial therapy. Quite an adequate requirement is the appointment of antibiotics in cases of exacerbation of cholecystitis, as well as concomitant disorders of the intestinal microbiocenosis. Empirically used derivatives of 8-hydroxyquinoline (ciprofloxacin), creating a secondary concentration in the biliary tract, imipenem, cefuroxime, cefotaxime, Ampiox, Sumamed, fluoroquinolones in combination with metronidazole. A limitation for the use of ceftriaxone is the formation of biliary sludge when it is taken. At the same time, a number of antibacterial drugs (tetracycline, rifampicin, isoniazid, amphotericin B) have a toxic effect on pancreatic acinar cells.

As a rule, in all patients with cholelithiasis, combined with CP, various degrees of severity of intestinal microbiocenosis disorders are detected, which significantly affect the course of the disease, the rate of regression of abdominal pain and dyspeptic syndromes. For its correction, the antibiotic rifaximin (Alfa-normix), which is not absorbed in the intestine, is used, which is prescribed 3 times a day, at a dose of 1200 mg / day, for 7 days.

It is mandatory to combine the stage of intestinal sanitation with the use of probiotics (live cultures of symbiotic microorganisms) and prebiotics (drugs that do not contain live microorganisms that stimulate the growth and activity of the symbiotic intestinal flora). Lactulose (Duphalac) has a proven prebiotic effect. Dufalac is the drug with the highest content of lactulose and the least amount of impurities. It belongs to synthetic disaccharides, the main mechanism of action of which is associated with their metabolism by colon bacteria to short-chain fatty acids that perform important physiological functions - both local, in the colon, and systemic, at the level of the whole organism. Clinical studies have shown that Dufalac has pronounced prebiotic properties, which are realized due to bacterial fermentation of disaccharides and increased growth of bifidus and lactobacilli, as well as a physiological laxative effect.

Normalization of digestion and absorption processes

For this purpose, buffer antacids and polyenzymatic preparations are used. An indication for the appointment of buffer antacids (Maalox, Phospholugel) in patients with cholelithiasis is their ability to:

• bind organic acids;
• increase intraduodenal pH;
• bind deconjugated bile acids, which reduces secretory diarrhea and their damaging effect on the mucosa;
• reduce the absorption of antibacterial drugs, which increases their concentration in the intestinal lumen, enhances the antibacterial effect and reduces side effects.

Indications for polyenzymatic medicines are:

• damage to the pancreas against the background of duodenal hypertension, increased intraluminal pressure in the ducts;
• violation of emulsification of fats;
• impaired activation of the chain of pancreatic proteolytic enzymes;
• violation of the contact time of food with the intestinal wall against the background of changes in peristalsis.

To correct these changes, it is advisable to use enzyme preparations with a high content of lipase, resistant to the action of hydrochloric acid, pepsin, with an optimum action at pH 5-7, in the form of mini-microspheres with a maximum contact surface with Creon-type chyme of 10,000-25,000 units.

Taking into account the above approaches to the treatment of cholelithiasis in practice, in specific groups, their individualization is expected. These schemes are presented in the form of stepwise therapy, which can be carried out both simultaneously and sequentially, depending on the clinical situation.

Group 1 — patients with gallstone disease without clinical symptoms

1st step. Normalization of bile rheology and prevention of stone formation: ursodeoxycholic acid (Ursosan) 8-15 mg/kg once in the evening until the sludge resolves (3-6 months).

2 step. Correction of intestinal dysbiosis: Duphalac 2.5-5 ml per day 200-500 ml per course, with a prebiotic purpose.

Prevention. 1-2 times a year for 1-3 months maintenance therapy with Ursosan at a dose of 4-6 mg / mg of body weight per day in combination with Duspatalin 400 mg / day orally in 2 doses 20 minutes before breakfast and dinner - 4 weeks.

Group 2 — patients with cholelithiasis with symptoms of functional biliary/pancreatic disorder or gallbladder disorder

1st step. Correction of motor-evacuation function and intraduodenal pH:

• Duspatalin 400 mg/day in 2 doses 20 minutes before meals - 4 weeks.
• Creon 10,000-25,000 units 1 capsule 3 times a day at the beginning of meals - 4 weeks.
• Antacid, 40 minutes after meals and at bedtime, up to 4 weeks.

• Alpha Normix 400 mg 3 times a day for 7 days.
• Duphalac 2.5-5 ml per day 200-500 ml per course with a probiotic.

3rd step. Normalization of bile rheology and prevention of stone formation: Ursosan - taken with 250 mg / day (4-6 mg / kg), then weekly increase in dose by 250 mg, up to 15 mg / kg. The drug is taken once in the evening until the sludge resolves (3-6 months).

Group 3 — patients with cholelithiasis with symptoms of chronic pancreatitis

1st step. Correction of pancreatic function:

• Omeprazole (Rabeprazole) 20-40 mg/day on an empty stomach in the morning and at 8 pm, 4-8 weeks.
• Duspatalin 400 mg/day in 2 doses 20 minutes before meals - 8 weeks.
• Creon 25,000-40,000 IU 1 capsule 3 times a day at the beginning of meals - 8 weeks.

2nd stage. Correction of intestinal dysbiosis:

• Alpha Normix 400 mg 3 times a day for 7 days.
• Duphalac 2.5-5 ml per day 200-500 ml per course, with a probiotic.

3rd step. Normalization of bile rheology and prevention of stone formation: Ursosan - from 250 mg / day (4-6 mg / kg) followed by a 7-14-day dose increase to 10-15 mg / kg of body weight, lasting up to 6-12 months. In the future, 2 times a year for 3 months or continuous maintenance therapy at a dose of 4-6 mg / kg / day in combination with Duspatalin 400 mg / day orally in 2 doses 20 minutes before breakfast and dinner for the first 4 weeks.

4th group - patients with cholelithiasis with symptoms of one or more attacks of biliary colic

• Diet - hunger, then individually.
• Hospitalization in a surgical hospital, where conservative treatment is carried out jointly with a gastroenterologist. When stopping colic, patients are managed as the 3rd group. If this fails, laparoscopic cholecystectomy is performed. The choice of an adequate type of treatment for cholelithiasis is largely determined by the mutually agreed tactics of the therapist (gastroenterologist), surgeon and patient.

Indications for surgical treatment in various groups are:

• in the 4th group: ineffectiveness of conservative therapy, according to urgent indications;
• in the 3rd group: after three stages of therapy in a planned manner, while, as a rule, surgical treatment is indicated even with a mild clinical picture of CP, both in patients with large (more than 3 cm) stones that create a risk of bedsores, and small ( less than 5 mm) with calculi, due to the possibility of their migration. It should be borne in mind that the removal of the gallbladder with calculi does not completely eliminate the factors that contributed to the development and progression of pancreatitis. So, against the background of disorders of bile secretion, leading to impaired digestion and absorption of food (malassimilation), due, first of all, to a deficiency of pancreatic enzymes (primary, associated with insufficient production, and secondary, due to their inactivation), subsequently in patients who underwent cholecystectomy, severe indigestion may occur;
• in the 2nd group: with the ineffectiveness of conservative choleretic therapy, in a planned manner, possibly after sphincteropapillotomy.

An important task of treatment is the therapeutic preparation of cholelithiasis patients for elective surgery, as well as their medical rehabilitation in the postoperative period. Due to the presence of mechanisms that disrupt normal bile secretion and digestion before and after surgery for cholelithiasis, therapy with modern minimicrospheric polyenzymatic drugs and antispasmodics with a eukinetic effect should be carried out. In addition, taking pancreatins and Duspatalin in the preoperative period is due to the need to achieve a full clinical remission of FBI and CP. For the same purposes, an additional appointment of agents that correct the state of intestinal microbiocenosis and ursodeoxycholic acid preparations is indicated. Therefore, patients who are scheduled to undergo cholecystectomy need preparatory (before surgery) and further (after surgery) drug correction. In fact, the preoperative preparation option includes the same principles and drugs that are used in planned therapy:

I stage

• Diet.
• Polyenzyme preparation (Creon 10,000-25,000 units) 4-8 weeks.
• Secretolitics, antacids, 4-8 weeks.
• Correction of motor-evacuation disorders (Duspatalin 400 mg/day) 4 weeks.

II stage

• Bacterial decontamination, course 5-14 days (ciprofloxacin, Alfa-normix).
• Prebiotic therapy (Duphalac 200-500 ml per course).
• probiotic therapy.

III stage

• Impact on the rheology of bile (Ursosan 15 mg / kg 1 time per day), if the clinical situation allows, a course of up to 6 months.

In the postoperative period, from the moment the fluid intake is allowed, the following are prescribed in parallel:

• Duspatalin 400 mg/day orally in 2 doses 20 minutes before meals, 4 weeks.
• Creon 25,000-40,000 units, 3 times a day with meals for 8 weeks, then 1 capsule at the maximum meal 1 time per day and on demand for 4 weeks.
• Secretolytic according to indications.

Supportive care includes:

• Ursosan 4-10 mg/kg/day, courses 2 times a year for 1-3 months.
• Duspatalin 400 mg / day - 4 weeks.
• Duphalac 2.5-5 ml per day 200-500 ml per course.

Dispensary observation of patients who have undergone cholecystectomy is carried out for at least 12 months and is aimed at the prevention and timely diagnosis of relapses of cholelithiasis and concomitant diseases of the organs of the pancreato-hepatoduodenal system. Dispensary observation should include regular examinations by a therapist and at least 4 times a year an examination by a gastroenterologist with a semi-annual control of laboratory parameters (ALT, AST, bilirubin, alkaline phosphatase, GGTP, amylase, lipase), ultrasound of the abdominal organs. According to the indications, it is possible to conduct fibrogastrodoudenoscopy (FGDS), MRI, etc.

Unfortunately, to date, there is no continuity in the management of patients with cholelithiasis. As a rule, these patients end up in surgical hospitals without prior examination and drug preparation, which significantly increases the risk of both surgical and postoperative complications. The first on this list is the formation of the so-called postcholecystectomy syndrome, which is a variant of FBI and exacerbation of CP. This is especially true for patients with clinical symptoms before surgical treatment.

Our experience in observing patients who underwent special outpatient and/or inpatient preparation for surgery, including stepwise therapy, led to the conclusion that in the case when a patient with cholelithiasis did not undergo preoperative therapy, clinical symptoms usually increased after surgery. Deterioration of the condition lengthened the postoperative period and required repeated requests for medical help as soon as possible after the patient was discharged from the surgical department. In those situations where such preparation was carried out, the postoperative course was smooth, with a minimum number of complications.

Thus, the formation of approaches to the treatment of cholelithiasis continues to be promising, while the proposed algorithm (see Table "Algorithm of therapeutic measures for cholelithiasis (GSD)" on page 56) allows not only the correct distribution of patients into clinical groups, but, taking into account the early and balanced use of modern pharmacotherapeutic agents, to achieve effective prevention and treatment of the disease, including full-fledged rehabilitation after cholecystectomy.

Literature

1. Diseases of the liver and biliary tract: A guide for physicians / Ed. V. T. Ivashkina. M.: M-Vesti Publishing House LLC, 2002. 416 p.
2. Burkov S.G. On the consequences of cholecystectomy or postcholecystectomy syndrome // Consilium medicum, gastroenterology. 2004. V. 6, No. 2, p. 24-27.
3. Burkov S. G., Grebenev A. L. Gallstone disease (epidemiology, pathogenesis, clinic) // Guide to gastroenterology. In three volumes. Under the general editorship of F. I. Komarov and A. L. Grebenev. T. 2. Diseases of the liver and biliary system. M.: Medicine, 1995, p. 417-441.
4. Grigoriev P. Ya., Yakovenko A. V. Clinical gastroenterology. M.: Medical Information Agency, 2001. 693 p.
5. Grigoriev P. Ya., Soluyanova I. P., Yakovenko A. V. Cholelithiasis and consequences of cholecystectomy: diagnosis, treatment and prevention // Treating Physician. 2002, no. 6, p. 26-32.
6. Lazebnik L. B., Kopaneva M. I., Ezhova T. B. The need for medical care after surgical interventions on the stomach and gallbladder (literature review and own data) // Ter. archive. 2004, no. 2, p. 83-87.
7. Leishner U. A practical guide to diseases of the biliary tract. M.: GEOTAR-MED, 2001. 234 p.
8. McNally P. R. Secrets of gastroenterology: Per. from English. M.-SPb.: ZAO BINOM Publishing House, Nevsky Dialect, 1998. 1023 p.
9. Petukhov VA Cholelithiasis and maldigestion syndrome. M.: Vedi, 2003. 128 p.
10. Sokolov V. I., Tsybyrne K. A. Cholepancreatitis. Kishinev: Shtiintsa, 1978. 234 p.
11. Sherlock S., Dooley J. Diseases of the liver and biliary tract: Prakt. hands: Per. from English. ed. Z. G. Aprosina, N. A. Mukhina. Moscow: Geotar Medicine, 1999. 864 p.
12. Yakovenko E. P., Grigoriev P. I. Chronic diseases of the extrahepatic biliary tract. Diagnosis and treatment. Toolkit for doctors. M.: Medpraktika-M, 2001. 31 p.
13. Yakovenko E. P. Intrahepatic cholestasis — from pathogenesis to treatment // Practitioner. 1998. No. 2 (13), p. 20-24.
14. Kuntz E., Kuntz H-D. Hepatology, Principles and practice: history, morphology, biochemistry, diagnostics, clinic, therapy. Berlin Heidelberg New York Springer Verlag, 2000. 825 p.
15. Rose S. (ed). Gastrointestinal and Hepatobiliary pathophysiology. Fence Greek Publishing, LLC, Madison, Connecticut, 1998. 475 p.

S. N. Mekhtiev*, doctor of medical sciences, professor
O. A. Mekhtieva**,Candidate of Medical Sciences, Associate Professor
R. N. Bogdanov***

* SPbGMU im. I. P. Pavlova,
** SPbGMA im. I. I. Mechnikova,
*** Hospital of the Holy Martyr Elizabeth, St. Petersburg

SCIENTIFIC SOCIETY OF GASTROENTEROLOGISTS OF RUSSIA ON DIAGNOSIS AND TREATMENT OF Cholelithiasis

CODE ON ICD-10

Gallstone disease (GSD) is a multifactorial and multistage disease of the hepatobiliary system, characterized by a certain clinical picture, impaired cholelithiasis metabolism.

1. Gallstone disease K 80

2. Gallbladder stones K 80.1

3. Stones of the bile duct K 80.2

sterol and / or bilirubin with the formation of gallstones in the bladder and / or bile ducts.

Gallstone disease affects 10 to 20% of the adult population. In women, the disease is more common. 2/3 of patients have cholesterol stones.

Clinical stages:

I stage - initial (prestone);

Stage II - the formation of gallstones;

Stage III - chronic calculous cholecystitis;

IV stage - complications.

1. ETIOLOGY

In most patients, cholelithiasis develops as a result of the complex influence of many risk factors, including:

1. Diet: food with an excess of carbohydrates and animal fats, poor in vegetable fibers and proteins; low-calorie diets with a rapid reduction in body weight; violation of the diet (eating at night).

2. Constitutional: heredity; hypersthenic type of constitution.

3. Medical: diabetes; dyslipoproteinemia; diseases of the liver, intestines, pancreas; intestinal dysmotility; infections of the biliary tract; hemolytic anemia; long-term parenteral nutrition; spinal injury.

4. Pharmacological: contraceptive drugs; fibrates; diuretics; octreotide, ceftriaxone.

5. Socio-hygienic: alcohol abuse; smoking; physical inactivity.

6. Psychological: frequent stressful situations, conflicts in the family and (or) at work.

7. Pregnancy, female gender, overweight.

2. PATHOGENESIS

Simultaneous presence of three main pathological processes - oversaturation of bile with cholesterol, a violation of the dynamic balance between antinucleating and pronucleating factors and a decrease in the contractile function of the gallbladder.

An important link in the formation of cholelithiasis is chronic biliary insufficiency caused by a deficiency of bile acids. Aggravating factors are violation of enterohepatic circulation of bile acids, psycho-vegetative dysfunction and neuro-humoral dysregulation and infection.

3. DIAGNOSIS

The diagnosis of cholelithiasis is made on the basis of the clinical picture, data from laboratory and instrumental research methods (screening method - transabdominal ultrasound).

CLINICAL SYMPTOMS

CLINICAL PICTURE AT THE STAGE OF BILIARY SLUDGE Biliary sludge (BS). This term refers to any heterogeneity of bile detected by echographic examination. The disease at this stage may be asymptomatic, accompanied by dyspeptic disorders or pain localized in the right hypochondrium (the “right hypochondrium” syndrome). CLINICAL PICTURE AT THE STAGE OF CHOLELITHIASIS

1. Asymptomatic lithiasis (latent course of cholelithiasis).

Occurs in 60-80% of patients with gallstones and 10-20% in the bile ducts Gallstones are an incidental finding during examination for other diseases. The period of latent stone-carrying on average lasts 10-15 years.

2. Painful form with typical biliary colic. In the general population of patients with cholelithiasis occurs in 7-10% of cases. It is manifested by sudden onset and usually recurring pain attacks of hepatic (biliary) colic. An attack is usually provoked by an error in diet or exercise, sometimes develops for no apparent reason. spasm of the sphincter of Oddi, its obturation with a stone, the passage of a stone through the common bile duct). According to surgical hospitals, this form is considered the most common manifestation of cholelithiasis.

3. Dyspeptic form. The frequency varies widely (30-80%) and depends on the thoroughness of the collected anamnesis. This form is characterized by the so-called "right hypochondrium syndrome", in the form of a feeling of heaviness, discomfort in the right hypochondrium, associated or not associated with meals. A third of patients complain of a feeling of bitterness in the mouth.

4. Under the guise of other diseases.

angina pectoris form. It was first described as a cholecystocardial syndrome in 1875 by S.P. Botkin. With this form of pain that occurs with hepatic colic, they spread to the region of the heart, provoking an attack of angina pectoris. Usually, after cholecystectomy, angina attacks disappear.

Saint's triad. The combination of cholelithiasis with diaphragmatic hernia and diverticulosis of the colon, described by Ch. E. M. Saint in 1948. The pathogenetic connection of the components of the triad is not clear, perhaps it is a genetic defect.

COMPLICATIONS OF CHOLECYSTOLITHIASIS

Acute calculous cholecystitis. Among patients with acute cholecystitis, 90% are patients with cholelithiasis. It occurs more often in the elderly. In acute cholecystitis, pathological changes occur in the wall of the gallbladder (sclerosis, circulatory disorders, etc.). It contributes to its development mechanical damage to the mucous membrane with calculi, a violation of the outflow of bile, due to partial or complete obstruction of the cystic duct. Infection (Escherichia or Pseudomonas aeruginosa, enterococci, etc.) joins for the second time. Ultrasound reveals a three-layered structure of the gallbladder wall.

Chronic calculous cholecystitis is the most common complication of cholelithiasis. It occurs more often in the form of a dyspeptic form, biliary colic develops rarely. Ultrasound reveals uneven thickening of the gallbladder wall.

A disabled gallbladder is one of the most common complications of cholecystolithiasis. Basic

The reason for the shutdown of the gallbladder is the wedging of a calculus into its neck, less often a clot of putty bile. A contributing factor is cervical cholecystitis.

Hydrocele of the gallbladder develops as a result of obstruction of the bile duct with an impacted calculus or a clot of putty-like bile, accompanied by the accumulation of transparent contents (serous effusion) with an admixture of mucus in the bladder. In this case, the gallbladder increases in volume, and its wall becomes thinner. On palpation - enlarged gallbladder, elastic, painless (Courvoisier symptom). Diagnose with ultrasound, sometimes supplemented by CT.

Gallbladder empyema develops against the background of a disabled gallbladder as a result of an infection. Clinical manifestations in some cases can be smoothed out, especially in the elderly, but may correspond to an intra-abdominal abscess.

Phlegmon of the gallbladder wall is the outcome of acute calculous cholecystitis.

Often accompanied by the formation of various fistulas. Diagnosis is based on data from clinical, laboratory and instrumental studies (ultrasound, CT).

Perforation of the gallbladder occurs due to transmural necrosis of the gallbladder wall as a result of a pressure sore of a large calculus and is accompanied by the formation of fistulas.

Biliary fistulas: are formed during necrosis of the gallbladder wall and are divided into:

a) biliodigestive (cholecystoduodenal, cholecystogastric, choledochoduodenal, etc.)

b) biliary (cholecystocholedochial, cholecystohepatic).

With infection of biliodigestive fistulas, cholangitis develops.

Biliary pancreatitis develops as a result of a violation of bile outflow and pancreatic secretion that occurs when a stone or biliary sludge passes from the gallbladder or common bile duct.

Mirizzi's syndrome develops as a result of wedging of a calculus into the neck of the gallbladder and the subsequent development of an inflammatory process, as a result of which compression of the common bile duct can occur, followed by the development of obstructive jaundice.

Intestinal obstruction due to gallstones is very rare (1% of all cases of perforation of the gallbladder and intestinal

obstruction). It develops as a result of a bedsore and subsequent perforation of the gallbladder wall with a large calculus and its entry into the small intestine. Intestinal blockage by a stone occurs in the narrowest part of the small intestine, usually 30–50 cm proximal to the ileocecal valve.

Gallbladder cancer. In 90% of cases, it is accompanied by cholecystolithiasis. A particularly high risk of malignancy occurs with long-term lithology (more than 10 years).

Choledocholithiasis

The frequency of choledocholithiasis in cholelithiasis is 15%, in the elderly and senile age - 30-35%. Fundamentally, the allocation of two types of choledocholithiasis - residual and recurrent. Calculi are considered recurrent, the formation of which is due to strictures, stenosis of the major duodenal papilla and the presence of foreign bodies (suture material) in the common bile duct.

Clinically, choledocholithiasis can be asymptomatic, or have severe symptoms (jaundice, fever, pain syndrome).

Transabdominal ultrasound scanning allows diagnosing ductal stones in 40-70% of cases. This is due to the fact that in some patients it is not possible to visualize the common bile duct throughout due to flatulence, adhesions after surgical interventions on the abdominal organs or pronounced subcutaneous fat of the anterior abdominal wall. In these situations, ultrasound is complemented by endoscopic retrograde cholangiopancreaticography (ERCP). Contraindications to the study, the possibility of complications, as well as the low incidence of stones less than 5 mm in diameter in the choledoch should be taken into account.

The "gold" standard in the diagnosis of choledocholithiasis should be considered endoscopic ultrasonography (EUS), the sensitivity of which is 96 - 99%, and the specificity - 81 - 90%.

A biochemical blood test with the study of the activity of ALT, AST, alkaline phosphatase, GGTP is shown.

OBJECTIVE

(PHYSICAL) EXAMINATION

Has approximate diagnostic value. With cholelithiasis complicated by acute cholecystitis, positive symptoms can be identified: Ortner (appearance of pain when tapping along the right costal arch), Zakharyin (presence of pain on palpation or percussion along the abdominal wall in the gallbladder area), Vasilenko (appearance of pain at percussion at the height of inhalation along the anterior abdominal wall in the projection of the gallbladder), Murphy (appearance at the height of inspiration of pain on palpation at the point of the gallbladder), Georgievsky-Mussi, or right-sided phrenicus - a symptom (the presence of pain

when pressing between the legs of the right sternocleidomastoid muscle). Courvoisier's symptom - an enlarged, tense and painful gallbladder is determined by palpation, which indicates a blockage of the common bile duct caused by choledocholithiasis, a tumor of the pancreas, a large duodenal papilla (OBD) or other causes, often accompanied by jaundice, skin itching.

Of clinical importance is the determination of Mackenzie, Bergman, Yonosh, Lapinsky points, which allow for a differential diagnosis with pancreatic pathology.

LABORATORY RESEARCH METHODS

Mandatory: clinical analysis blood, urinalysis, urine diastasis, biochemical blood test (total bilirubin and fractions, total protein, glucose, amylase, total cholesterol, ALT, AST, alkaline phosphatase, GGTP), blood type, Rh factor. Blood test for NRS, HIV, viral markers (HBsAg; anti-HCV). Blood lipid spectrum with the determination of the coefficient of atherogenicity (Cholesterol, HDL, LDL-C, triglycerides (TG), phospholipids), biochemical study of bile obtained by duodenal sounding (cholesterol, bile acids, phospholipids with the calculation of the cholate-cholesterol coefficient (CHC) and phospholipid-cholesterol ratio (PCC).

In uncomplicated cholelithiasis, laboratory parameters, as a rule, are not changed. After an attack of biliary colic in 30-40% of cases, there is an increase in serum transaminase activity, in 20-25% of alkaline phosphatase, GGTP, in 20-45% of bilirubin levels. As a rule, a week after the attack, the indicators return to normal. If the disease is complicated by acute calculous cholecystitis, then leukocytosis and an increase in ESR are noted.

Additional:

Morphometric study of bile (crystallography) by polarizing microscopy to determine the features of the structure of bile. Changes in the morphological picture of bile begin already at an early stage of cholelithiasis, the optical structure of the crystals changes depending on the duration of the disease.

INSTRUMENTAL RESEARCH METHODS

Transabdominal ultrasonography (TUS) is the main diagnostic method. In most cases, it provides high-quality visualization of all parts of the gallbladder and biliary tract. Allows you to study the location, shape of the gallbladder, the thickness and structure of its wall, the nature of the intraluminal contents, as well as displacement when the patient's position changes and the presence of local pain during instrumental palpation during TUS (positive

Murphy's sonographic sign). In most cases, various sections of the common bile duct are available for examination, which allows obtaining information about its width, the condition of the wall, the presence of calculi, bile putty and other pathologies. The sensitivity of the method is 37-94%, and the specificity is 48-100%.

Normally, the gallbladder has smooth and clear contours, its contents are echo-homogeneous. When BS can be detected: suspended sediment in the form of small particles; stratification of bile with the formation of a horizontal level "liquid - liquid"; the formation of clots of echogenic bile, displaced or fixed to the wall of the gallbladder; a total increase in the echogenicity of bile, approaching the liver parenchyma (putty bile). It should be borne in mind that putty-like bile makes accurate diagnosis difficult, since it either masks the presence of small and even medium-sized gallstones, or “glues” the stones, making them difficult to visualize. It is recommended to allocate the following forms of BS:

Microlithiasis (suspension of hyperechoic particles: dotted, single or multiple, displaced, not giving an acoustic shadow);

Putty-like bile (echo-hemogeneous bile with the presence of areas approaching the echogenicity of the liver parenchyma, displaced or fixed to the wall of the gallbladder);

Combination of putty bile with microliths. At the same time, microliths can be both in the composition of a clot of putty-like bile and in the cavity of the gallbladder.

Endoscopic ultrasonography (EUS). Allows a more qualitative assessment of the extrahepatic bile ducts throughout, the OBD area, to clarify the nature of pathological changes in the gallbladder wall. The introduction of EUS into clinical practice for suspected choledocholithiasis can significantly reduce the number of diagnostic ERCPs. In patients with acute pancreatitis of unknown etiology, EUS makes it possible to identify or exclude the biliary etiology of pancreatitis (choledocholithiasis, OBD pathology), intraductal mucin-producing neoplasias (IMED, tumors, cystic formations), determine their topographic location, and, if necessary, perform a fine needle puncture (TYP) of a pathological formation.

Endoscopic retrograde cholangiopancreaticography (ERCP) is indicated to detect choledocholithiasis, stenosis, stricture, cysts, polyps, diverticula and other pathologies of the common bile duct, as well as the main pancreatic duct (MPD). The sensitivity of the method in the detection of choledocholithiasis is 70 - 80%, specificity - 80-100%. Due to frequent complications (danger of developing ERCP-associated pancreatitis) ERCP for diagnostic purposes

should be used for more stringent indications. For these purposes, it is advisable to more often use non-invasive research methods (EUS, MRCP).

Esophagogastroduodenoscopy (EGDS). Allows you to identify diseases of the stomach and duodenum, which are a possible cause of pathology of the biliary tract or abdominal pain syndrome, to diagnose the pathology of OBD.

To determine the motor-evacuation function of the gallbladder and the tone of the sphincter apparatus of the biliary tract, the following are shown:

1. Dynamic ultrasonic cholecystography according to the generally accepted method, which consists in measuring the volume of the gallbladder before and after a choleretic breakfast with a 10-minute interval, for 1.5 hours;

2. Dynamic hepatobiliary scintigraphy with assessment of bile secretory function of the liver by the time of maximum accumulation of the radiopharmaceutical in the liver (Tmax of the liver), bile excretory function of the liver - by the half-life of the radiopharmaceutical from the liver (TH of the liver), which deposits the function of the gallbladder by the time of maximum accumulation of the radiopharmaceutical in the gallbladder (Tmax GB), motor-evacuation function of the gallbladder - by the half-life of the radiopharmaceutical from the gallbladder (TU GB) and the latent time of the choleretic breakfast (LVZhZ).

Plain radiography of the abdominal cavity allows you to determine the x-ray positivity / negativity of stones detected by ultrasound in the gallbladder or biliary tract.

Multispiral computed tomography (MSCT) of the abdominal cavity with intravenous contrast is one of the most accurate imaging methods (sensitivity - 56-90%, specificity - 85-90%), has an advantage over CT. It is indicated to clarify the nature of the lesion of the gallbladder wall and its relationship with surrounding organs in order to exclude the tumor process.

Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreaticography (MRCP) allow you to get a direct image of the biliary system, pancreatic ducts, perform non-contrast angiography and cholecystocholangiography. Indicated in the presence of multiple calculi of the ductal system, regardless of their location, with suspicion of intraductal tumors. MRCP can detect irregular narrowing of the main pancreatic duct (if

on autoimmune pancreatitis), strictures in the choledoha and intrahepatic ducts.

^^ Duodenal sounding, in particular, the stage-

^ noe chromatic duodenal sounding

1 (ECHD) with graphic registration of bile secretion,

=■= calculation of the stimulated hourly flow of bile

¡! and the study of the hourly debit of hepatic bile and its

^ components. Provides an opportunity within one

^ 5 studies to diagnose violations of the processes of bile formation, bile secretion, motility of the biliary tract, and also to determine the types of cholelithiasis of hepatic bile secretion. Biochemical research-¡3 § dovanie bile allows you to determine its quality-| composition, to diagnose the degree of chronic * biliary insufficiency. The study also I can verify lithogenic bile and ob-| activate the processes of inflammation and healing. ^ In Definition of Psycho-Vegetative State

™ patients:

° а__а) study of the vegetative nervous system

(vegetative tone, vegetative reactivity and vegetative support of activity);

b) study of psychological status (reactive anxiety, personal anxiety and depression).

4. TREATMENT

4. I. CONSERVATIVE TREATMENT

The tactics of managing patients with cholelithiasis should be differentiated depending on the stage of the disease 4.1.1. TACTICS OF MANAGEMENT OF PATIENTS AT THE STAGE OF BILIARY SLUDGE

1. Patients with newly diagnosed biliary sludge in the form of suspended hyperechoic particles, in the absence of clinical symptoms, should be prescribed diet therapy (fractional nutrition and limiting the intake of easily digestible carbohydrates and cholesterol-containing products) and dynamic observation with repeated ultrasound after 3 months. If biliary sludge persists, medication should be added to diet therapy.

2. Patients with biliary sludge in the form of echo-heterogeneous bile with the presence of clots and smear-like bile, regardless of clinical symptoms, need conservative therapy.

3. The basic drug for all forms of BS is UDCA, which is prescribed at a dose of 10-15 mg/kg of body weight once a night for 1-3 months with monthly control ultrasound. On average, the total duration of treatment usually does not exceed 3 months. In BS occurring against the background of hypotension of the gallbladder and (or) hypertonicity of the sphincter of Oddi, it is advisable to add mebeverine hydrochloride (Duspatalin) 200 mg 2 times a day to UDCA

I or gimecromon (Odeston) 400 mg 3 times a day. ™ In violation of psycho-emotional and (or) vegetative balance - 2-mercaptobenzimidazole

(Afobazole) at a dose of 10 mg 3 times a day until the sludge disappears completely. The complex of conservative therapy shows the inclusion of organ preparations - Enterosan and Hepatosan, since they have a hypolipidemic effect, affecting the synthesis of cholesterol in the hepatocyte and its absorption in the intestine. In combination with UDCA preparations, which normalize the colloidal stability of bile and reduce the transport of cholesterol into the gallbladder wall, they have a corrective effect on cholesterol catabolism at different levels. 4.1.2. TACTICS OF MANAGEMENT OF PATIENTS AT THE STAGE OF CHOLECYSTOLITHIASIS

In connection with the widespread introduction of laparoscopic cholecystectomy into clinical practice, conservative methods of treatment for cholelithiasis have faded into the background, but have not lost their importance. 4.1.2.1. Oral litholytic therapy. Of the general population of patients with cholelithiasis, 20-30% can be subjected to litholytic therapy. For oral litholytic therapy, bile acid preparations are used. The litholytic effect of bile acids has been well studied. Chenodeoxycholic acid (CDCA) replaces the deficiency of bile acids in bile, inhibits the synthesis of cholesterol in the liver, forms micelles with cholesterol and, ultimately, reduces the lithogenic properties of bile. Ursodeoxycholic acid (UDCA) reduces the saturation of bile with cholesterol by inhibiting its absorption in the intestine, suppressing synthesis in the liver, and reducing secretion into bile. In addition, UDCA slows down the precipitation of cholesterol (increases the nucleation time) and promotes the formation of liquid crystals.

4.1.2.1. 1. Indications for litholytic therapy.

1. Clinical:

Absence of biliary colic or rare attacks;

Absence of obstruction of the patency of the extrahepatic bile ducts;

If the patient does not agree to cholecystectomy in order to stabilize the process of stone formation.

2. Ultrasonic:

The size of a single calculus is not more than 1 cm.

Homogeneous, low echogenic structure of the stone.

Rounded or oval shaped calculus.

The surface of the calculus is close to even or in the form of a "mulberry". Stones with a polygonal surface are excluded.

Weak (poorly visible) acoustic shadow behind the calculus.

The diameter of the acoustic shadow is less than the diameter of the calculus.

Slow fall of the calculus with a change in body position.

Multiple small stones with a total volume of less than 1/4 of the volume of the gallbladder on an empty stomach.

The coefficient of emptying of the gallbladder is not less than 30 - 50%.

The daily dose of UDCA (10-15 mg / kg) is taken once in the evening before bedtime (during the period of maximum functional rest of the gallbladder). HDCA is prescribed in a daily dose of 12-15 mg/kg. A combination of HDCA and UDCA is acceptable at 7-10 mg/kg per day each.

4.1.2.1. 2. Contraindications to litholytic therapy

pigment stones;

Cholesterol stones with a high content of calcium salts;

(according to CT, the Hounsfield attenuation coefficient (KOH) > 70 units);

Stones more than 10 mm in diameter;

Stones filling more than 1/4 of the volume of the bladder;

Decreased contractile function of the gallbladder (empty rate< 30%);

Frequent biliary colic in history (should be considered a relative contraindication, because in some patients, on the background of litholytic therapy, the frequency of biliary colic decreases or they disappear altogether);

Severe obesity. The effectiveness of litholytic therapy depends on the careful selection of patients, the duration of treatment and varies widely. The effectiveness of litholytic therapy is higher with early detection of cholelithiasis and significantly lower in patients with long-term stone bearing due to calcification of stones. With preserved contractile function of the gallbladder (SFZHP), the effectiveness of therapy is higher compared to that with reduced SFZhP.

The effectiveness of treatment is monitored by ultrasound, which must be performed every 3 months. The lack of positive dynamics after 6 months of therapy is the basis for its cancellation and the decision on surgical treatment.

In the treatment of HDCA, approximately 10% of patients experience diarrhea and an increase in the levels of aminotransferase activity, which requires the withdrawal or reduction of the dose of the drug, followed by its increase to therapeutic. In this regard, litholytic therapy requires biochemical monitoring of the level of aminotransferase activity every 3 months. When using UDCA, side effects are very rare (no more than 2-5%). In cases resistant to therapy, it is advisable to combine UDCA and CDCA or increase the dose of UDCA to 15-20 mg/kg per day.

Pregnancy is not a contraindication to the appointment of UDCA.

Before prescribing litholytic therapy, the doctor should inform the patient that:

Treatment is long and expensive;

Against the background of treatment, biliary colic may occur, including the need for surgical treatment;

Successful dissolution does not rule out stone recurrence. 4.1.2.2. Extracorporeal percussive

wave lithotripsy (ESWL)

Extracorporeal shock wave lithotripsy (ESWL) - the destruction of stones using shock waves induced by a generator. According to researchers, 20% of patients with cholelithiasis have indications for ESWL. The method is currently used as a preparatory step for subsequent oral litholytic therapy. As a result of crushing stones, their total surface increases, which sharply reduces the course of litholytic therapy.

4.1.2.2. 1. Indications for ESWL

Functioning gallbladder (emptying rate after a choleretic breakfast is at least 50%);

Passable bile ducts;

Radiolucent stones or calculi with a weak acoustic shadow, calculi with a powerful acoustic shadow, fan-shaped diverging from its surface, are excluded;

The total volume of stones is not more than the volume of the gallbladder on an empty stomach;

The size of the stones is not more than 3 cm and not less than 1.0 cm;

Absence of cavity formations along the course of the shock wave;

No coagulopathy.

4.1.2.2. 2. Contraindications to ESWL

The presence of coagulopathy;

Ongoing anticoagulant therapy;

The presence of a cavity formation along the course of the shock wave.

With proper selection of patients for lithotripsy, stone fragmentation is achieved in 90-95% of cases. Lithotripsy is considered successful if it is possible to achieve the destruction of calculi to a diameter< 5 мм. В ряде случаев билиарный сладж препятствует качественной ЭУВЛ. В подобных случаях предпочтителен предварительный 3-месячный курс литолитической терапии с последующей ЭУВЛ. При литотрипсии крупных камней требуется достаточно высокая мощность ударной волны. Для профилактики осложнений после дробления крупных камней (блок желчных путей образовавшимися многочисленными фрагментами, желчная колика, повышение активности трансаминаз, острый холецистит) целесообразно разрушить наиболее крупный из них на несколько мелких, затем провести 3-месячный курс пероральной литолитической терапии и вновь повторить ЭУВЛ с фрагментацией оставшихся камней до необходимого диаметра. После ЭУВЛ назначают препараты желчных кислот в тех же дозах, что и при пероральной литолитической терапии.

Complications of ESWL:

biliary colic;

Acute calculous cholecystitis;

Hypertrasaminasemia;

Block of extrahepatic bile ducts,

Micro and macrohematuria.

4.1.2.3. Contact dissolution of gallstones

In contact litholysis, the dissolving agent is injected directly into the gallbladder or into the bile ducts under X-ray or ultrasound guidance. In clinical practice, a number of drugs are used: methyl tert-butyl ether, isopropyl acetate, ethyl propionate, acetylcysteine, monooctanoin, etc. Indications for the use of contact litholysis are X-ray negative (cholesterol) gallstones, the density of which does not exceed 100 units. X. Relative contraindications - anomalies in the development of the gallbladder that make the procedure difficult, large stones or calculi occupying a significant part of the gallbladder. Absolute contraindications: disabled gallbladder, pregnancy.

4.1.3. Tactics of managing patients with asymptomatic stone carrying

The decision on surgical treatment of patients with asymptomatic stone carrying should be made in each case individually, taking into account the indications and contraindications to the above conservative methods of treatment.

It should be remembered that the rejection of expectant management of patients with asymptomatic stone carrying and the recommendation of an earlier cholecystectomy contributes to the prevention of complications of cholelithiasis, including gallbladder cancer.

4.1.4. The tactics of introducing patients at the stage of chronic calculous cholecystitis

4.1.4. 1. Antibacterial therapy It is prescribed for exacerbation of chronic calculous cholecystitis, which is clinically characterized, as a rule, by increased pain in the right hypochondrium, increased frequency of attacks of biliary colic, fever, leukocytosis, accelerated ESR, and according to ultrasound - thickening, three-layer wall of the gallbladder bubble, the blurring of its contours, an increase in the amount of sludge, especially putty bile.

Semi-synthetic penicillins: amoxicillin (flemoxin solutab, ospacmox) amoxicillin + clavulanic acid (amoxiclav, augmentin) orally 500 mg 2 times a day - 7-10 days. *

Macrolides: clarithromycin (clacid**, fromilid) 500 mg 2 times a day orally - 7-10 days.*

Cephalosporins: cefazolin (kefzol, nacef), cefatoxime (claforan) 1.0 g every 12 hours i / m - 7 days. *

Fluoroquinolones: ciprofloxacin (ciprolet, qi-probay), 250 mg 4 times a day orally - 7 days; pefloxacin (abactal) 400 mg twice a day orally for 7 days.*

Nitrofurans: furazolidone 50 mg 4 times a day, nitroxoline 50 mg 4 times a day orally for 10 days.***

4.1.4.2. Relief of pain syndrome

Drotaverine hydrochloride (no-shpa) 2% solution 2.0-4.0 ml as monotherapy or in combination with other antispasmodics or

Metamizil sodium (baralgin, spazgan) 5.0 IV drip for 3-5 days.

After the relief of acute pain, a transfer to selective myotropic agents for the correction of biliary dysfunction of the gallbladder and sphincter apparatus (mebeverine hydrochloride, etc.) is indicated.

4.1.4.3. Correction of biliary dysfunctions (hypertonicity of the sphincter of Oddi)

Mebeverine (Duspatalin) inside 200 mg - 1 capsule 2 times a day - 14 days up to 1 month or more or

Hymecromon (Odeston) inside 200 mg - 1 tab. 3 times a day - 14 days or

Domperidone (motilium, motilac, passage) inside 10 mg - 1 tab. 3 times a day - 14 days.

4.1.4.4. Enzyme replacement therapy It is used for chronic biliary pancreatitis, the course of which is accompanied by external non-secretory pancreatic insufficiency.

For enzyme replacement therapy, enteric-coated microencapsulated preparations (Creon 10/25/40000 IU FIP lipase, Hermital, etc.) are currently recommended. Doses of drugs depend on the degree exocrine insufficiency:

With normal exocrine function of the pancreas (elastase test data) - 1 capsule of Creon 10,000-5 times a day;

With moderate exocrine insufficiency, 2 capsules of Creon 10,000-5 times a day;

With severe exocrine insufficiency - 1 capsule of Creon 25000-6 times a day. The general course of treatment is 6 months. and more. The use of tablet preparations

and even more so, enzyme preparations containing bile acids are not indicated for enzyme replacement therapy.

* They are used in the presence of a pronounced exacerbation: pain syndrome, changes in blood tests and in the presence of an echographic picture indicating an inflammatory process in the gallbladder (3-layer wall of the gallbladder, its thickening is more than 3 mm).

** prolongs the QT interval with the threat of paroxysmal ventricular tachycardia.

*** They are used for mild course of the disease: the pain syndrome is not pronounced, with ultrasound - a slight thickening of the gallbladder wall, in the clinical analysis of blood without changes.

4.2. SURGERY

It occupies a leading position in the treatment of patients with cholelithiasis and is the removal of the gallbladder along with stones or only stones from the bladder. In this regard, the following types of surgical interventions are distinguished:

Traditional (standard, open) cholecystectomy;

Operations of small accesses (videolaparoscopic and "open laparoscopic" cholecystectomy from mini-access);

Cholecystolithotomy.

4.2.1. INDICATIONS FOR SURGICAL TREATMENT

For cholecystolithiasis:

Cholecystolithiasis with the presence of large and / or small stones of the gallbladder, occupying more than x / z of the volume of the gallbladder;

Cholecystolithiasis, regardless of the size of the stones, occurring with frequent attacks of biliary colic;

Cholecystolithiasis in combination with reduced contractile function of the gallbladder (the emptying rate after a choleretic breakfast is less than 30%);

Cholecystolithiasis, disabled gallbladder;

Cholecystolithiasis in combination with choledocholithiasis;

Cholecystolithiasis complicated by cholecystitis and/or cholangitis;

Cholecystolithiasis complicated by Mirizzi's syndrome;

Cholecystolithiasis, complicated by the development of dropsy or empyema of the gallbladder;

Cholecystolithiasis complicated by penetration, perforation, fistulas;

Cholecystolithiasis complicated by biliary pancreatitis.

For choledocholithiasis:

The question of the tactics of managing patients and indications for surgical treatment is decided together with the surgeon. At the same time, preference in the choice of surgical treatment of choledocholithiasis should be given to endoscopic methods.

The group with an increased operational risk consists of patients with severe concomitant diseases:

IHD 3-4 FC, severe pulmonary heart failure;

Severe decompensated form of diabetes mellitus;

Uncorrectable disorders of blood coagulation.

4.2.2. PREVENTION

POSTCHOLECISTECTOMIC SYNDROME The incidence of postcholecystectomy syndrome (PCS) after surgery reaches 40-50%. For the prevention of PCES, it is advisable to follow the following recommendations:

Operative intervention for cholelithiasis should be performed before the development of complications of the disease;

Comprehensive examination of patients in the preoperative period, regardless of the severity of clinical symptoms, in order to identify functional and organic pathology of the biliary tract and correct the identified disorders. To improve the accuracy of diagnostics, use EUS and ECDZ more widely;

Patients with cholesterol cholecystolithiasis are shown to have courses of therapy with UDCA drugs at a standard dose of 10-15 mg/kg of body weight for one month before surgery and one month after surgery, and then, depending on the degree of biliary insufficiency detected;

In the presence of hypercholesterolemia, as well as in the combination of cholecystolithiasis with cholesterosis of the gallbladder, one month before surgery and one month after surgery, courses of therapy with UDCA at a dose of 15 mg/kg of body weight are indicated;

For the prevention of recurrent choledocholithiasis with dysfunction of the sphincter of Oddi (hypertonicity), the use of myotropic antispasmodics (mebeverine hydrochloride in a standard dose) is indicated for 1-2 months;

Early rehabilitation of patients after cholecystectomy in a specialized gastroenterological sanatorium;

Dispensary observation of patients after cholecystectomy for 1 year.

4.3. REHABILITATION

Compliance with the diet and diet with the restriction of fatty, spicy and fried foods;

The use of mineral waters with low salinity and a predominance of hydrocarbonate anions.

4.4. SPA TREATMENT

Shown after successful litholytic therapy in sanatoriums of the gastrointestinal profile such as Borjomi, Erino, Monino, Zheleznovodsk, Krainka, Truskavets. In the asymptomatic course of cholecystolithiasis, the use of sanatorium-resort factors should be careful; in the often recurrent course of chronic calculous cholecystitis, it is contraindicated.

4.5. TREATMENT OUTCOME REQUIREMENTS

Clinical remission of the disease and normalization of laboratory parameters:

The disappearance of pain and dyspeptic syn-

O^ drom;

^^ normalization of biochemical parameters

1 definition of tactics for further management of pain

Leg (litholytic therapy, surgical

¡! treatment).

- „ 5. PREVENTION OF CHOLELITIASIS

£ ё Carried out at stage I of cholelithiasis. Treatment

£ r is given depending on the presence or absence

¡3 § Biliary dysfunctions. In the absence of biliary

| dysfunctions - UDCA at a daily dose of 10 mg/kg

body; in the presence of biliary dysfunction - UDCA at a daily dose of 10 mg/kg of body weight, 2-mercapto-benzimidazole 10 mg 3 times a day, mebeverine 200 mg 2 times a day or hymecromone 400 mg 3 times a day. In both cases, a cycle of classes at the health school is conducted for patients, patients are registered with the dispensary. As a preventive therapy for the prevention of gallstone formation, it is advisable to repeat the courses of treatment according to the selected schemes at least once a year. The recommended course is 30 days. The issue of prolonging treatment in each case is decided individually, taking into account the results of clinical and laboratory-instrumental studies.

When biliary sludge is detected, the algorithm of actions is as follows:

1. dynamic ultrasonic cholecystography to determine the presence of biliary dysfunctions (tone of the gallbladder and sphincter of Oddi);

2. treatment according to the developed schemes (see paragraphs 4.1.1. and 5 "prevention of gallstone formation");

3. education in the school of health;

4. dispensary registration.

LIST OF ABBREVIATIONS

BDS - major duodenal papilla

BS - biliary sludge

cholelithiasis - cholelithiasis

MPD - main pancreatic duct

duodenum - duodenum

KO - emptying factor

CT - computed tomography

KOH - Hounsfield attenuation coefficient

MRI - magnetic resonance imaging

MRCP - magnetic resonance cholangiopan-

creatography

MSCT - multislice computed tomography

CBD - common bile duct PZh - pancreas Ultrasound - transabdominal ultrasound

EGDS - esophagogastroduodenoscopy

EPST - endoscopic papillosphincterotomy

ERCP - endoscopic retrograde cholan-

giopancreatography

EUS - endosonography

ECHD - staged chromatic duodenal sounding

EXPERTS WHO HOSTED

prof. S. A. Alekseenko (Khabarovsk), MD E. V. Bystrovskaya (Moscow), MD O. S. Vasnev (Moscow), prof. Ya. M. Vakhrushev (Izhevsk), prof. V. A. Galkin (Moscow), Dr. Pharm. n. L. V. Gladskikh (Moscow), prof. I. N. Grigorieva (Novosibirsk), prof. V. B. Grinevich (St. Petersburg), prof. R. A. Ivanchenkova (Moscow), prof.

A. A. Ilchenko (Moscow), prof. L. B. Lazebnik (Moscow), prof. I. D. Loranskaya (Moscow), prof., corresponding member. RAMS I. V. Maev (Moscow), prof. V. A. Maksimov (Moscow), prof. O. N. Minushkin (Moscow), Ph.D. Yu. N. Orlova (Moscow), prof. A. I. Paltsev (Novosibirsk), prof. R. G. Saifutdinov (Kazan), MD E. Ya. Selezneva (Moscow), prof. R. M. Filimonov (Moscow), prof.

B. V. Tsukanov (Krasnoyarsk), prof. V. V. Chernin (Tver), prof. A. L. Chernyshev (Moscow), prof. L. A. Kharitonova (Moscow), prof. S. G. Shapovalyants (Moscow), prof. E. P. Yakovenko (Moscow).

The human body is a reasonable and fairly balanced mechanism.

Among all infectious diseases known to science, infectious mononucleosis has a special place ...

The disease, which official medicine calls "angina pectoris", has been known to the world for a long time.

Mumps (scientific name - mumps) is an infectious disease ...

Hepatic colic is a typical manifestation of cholelithiasis.

Cerebral edema is the result of excessive stress on the body.

There are no people in the world who have never had ARVI (acute respiratory viral diseases) ...

A healthy human body is able to absorb so many salts obtained from water and food ...

Bursitis of the knee joint is a widespread disease among athletes...

The most common chronic diseases of the gallbladder and biliary tract include chronic cholecystitis.

Chronic cholecystitis is an inflammatory disease that causes damage to the gallbladder wall, the formation of stones in it, and motor-tonic disorders of the biliary system. It develops gradually, rarely after acute cholecystitis. In the presence of stones, they speak of chronic calculous cholecystitis, in their absence, chronic acalculous cholecystitis. Often occurs against the background of other chronic diseases of the gastrointestinal tract: gastritis, pancreatitis, hepatitis. Women suffer more often.

The development of chronic cholecystitis is caused by bacterial flora (E. coli, streptococci, staphylococci, etc.), in rare cases, anaerobes, helminthic invasion (opisthorchia, giardia) and fungal infection (actinomycosis), hepatitis viruses. There are cholecystitis of toxic and allergic nature.

The penetration of microbial flora into the gallbladder occurs by enterogenous, hematogenous or lymphogenous routes. A predisposing factor in the occurrence of cholecystitis is stagnation of bile in the gallbladder, which can be caused by gallstones, compression and kinks of the bile ducts, dyskinesia of the gallbladder and biliary tract, impaired tone and motor function of the biliary tract under the influence of various emotional stresses, endocrine and autonomic disorders, pathological reflexes of altered organs of the digestive system. The stagnation of bile in the gallbladder is also facilitated by the prolapse of the viscera, pregnancy, a sedentary lifestyle, rare meals, etc .; the reflux of pancreatic juice into the biliary tract during their dyskinesia with its proteolytic effect on the mucous membrane of the bile ducts and gallbladder is also important.

The immediate trigger for an outbreak of the inflammatory process in the gallbladder is often overeating, especially the intake of very fatty and spicy foods, the intake of alcoholic beverages, an acute inflammatory process in another organ (tonsillitis, pneumonia, adnexitis, etc.).

Chronic cholecystitis may occur after acute cholecystitis, but more often develops independently and gradually, against the background of cholelithiasis, gastritis with secretory insufficiency, chronic pancreatitis and other diseases of the digestive system, obesity. Risk factors for the development of chronic cholecystitis are presented in Table 1.

Chronic cholecystitis is characterized by dull, aching pain in the right hypochondrium of a permanent nature or occurring 1–3 hours after ingestion of abundant and especially fatty and fried foods. The pain radiates up to the area of ​​the right shoulder and neck, right shoulder blade. Periodically, there may be a sharp pain, resembling biliary colic. Dyspeptic phenomena are not uncommon: a feeling of bitterness and a metallic taste in the mouth, belching with air, nausea, flatulence, impaired defecation (often alternating constipation and diarrhea), as well as irritability, insomnia.

Jaundice is not typical. On palpation of the abdomen, as a rule, sensitivity is determined, and sometimes severe pain in the projection of the gallbladder on the anterior abdominal wall and slight muscular resistance of the abdominal wall (resistance). The symptoms of Mussi-Georgievsky, Ortner, Obraztsov-Murphy are often positive. The liver is somewhat enlarged, with a dense and painful edge on palpation in case of complications (chronic hepatitis, cholangitis). The gallbladder in most cases is not palpable, as it is usually wrinkled due to a chronic cicatricial sclerosing process. During exacerbations, neutrophilic leukocytosis, an increase in ESR and a temperature reaction are observed. With duodenal sounding, it is often not possible to obtain a cystic portion of B bile (due to a violation of the concentration ability of the gallbladder and a violation of the cystic reflex), or this portion of bile has a slightly darker color than A and C, often cloudy. Microscopic examination of the duodenal contents reveals a large amount of mucus, desquamated epithelial cells, leukocytes, especially in portion B of bile (the detection of leukocytes in bile is not as important as before; as a rule, they turn out to be the nuclei of decaying cells of the duodenal epithelium). Bacteriological examination of bile (especially repeated) allows you to determine the causative agent of cholecystitis.

With cholecystography, a change in the shape of the gallbladder is noted, often its image is fuzzy due to a violation of the concentration ability of the mucosa, sometimes stones are found in it. After taking the irritant - cholecystokinetics - there is an insufficient contraction of the gallbladder. Signs of chronic cholecystitis are also determined by ultrasound (in the form of thickening of the walls of the bladder, its deformation, etc.).

The course in most cases is long, characterized by alternating periods of remission and exacerbation; the latter often occur as a result of eating disorders, taking alcoholic beverages, hard physical work, the addition of acute intestinal infections, and hypothermia.

The prognosis is favorable in most cases. The deterioration of the general condition of patients and the temporary loss of their ability to work are characteristic only during periods of exacerbation of the disease. Depending on the characteristics of the course, latent (sluggish), the most common - recurrent, purulent-ulcerative forms of chronic cholecystitis are distinguished.

Complications: accession of chronic cholangitis, hepatitis, pancreatitis. Often the inflammatory process is a "push" to the formation of stones in the gallbladder.

Diagnosis of chronic cholecystitis

Diagnosis of chronic cholecystitis is based on the analysis of:

• anamnesis (characteristic complaints, very often there are other patients with biliary tract pathology in the family) and the clinical picture of the disease;
• ultrasound data;
• results of computed tomography of the hepatopancreatobiliary zone, hepatoscintigraphy;
• clinical and biochemical parameters of blood and bile;
• indicators of coprological research.

A distinctive feature of the diagnosis of chronic cholecystitis is duodenal sounding followed by microscopic and biochemical studies of the composition of bile.

Duodenal sounding is carried out in the morning on an empty stomach. The best choleretic agent used to obtain portions B and C during duodenal sounding is cholecystokinin, when using which duodenal bile contains much less impurities of gastric and intestinal juices. It has been proven that it is most rational to produce fractional (multi-moment) duodenal sounding with an accurate account of the amount of bile released over time. Fractional duodenal sounding allows you to more accurately determine the type of bile secretion.

The process of continuous duodenal sounding consists of 5 stages. The amount of bile released for every 5 minutes of probing is recorded on a graph.

The first stage is the time of choledochus, when light yellow bile flows out of the common bile duct in response to irritation of the duodenal wall with an olive probe. Collect 3 servings of 5 minutes each. Normally, the rate of bile secretion of portion A is 1-1.5 ml / min. At a higher rate of bile flow, there is reason to think about hypotension, at a lower rate - about hypertension of the common bile duct. Then, a 33% solution of magnesium sulfate is slowly introduced through the probe (within 3 minutes) (according to the return of the patient - 2 ml per year of life) and the probe is closed for 3 minutes. In response to this, a reflex closure of the sphincter of Oddi occurs, and the flow of bile stops.

The second stage is the "time of the closed sphincter of Oddi". It starts from the moment the tube is opened until bile appears. In the absence of pathological changes in the biliary tract system, this time for the specified stimulus is 3-6 minutes. If the "time of the closed sphincter of Oddi" is more than 6 minutes, then spasm of the sphincter of Oddi is assumed, and if less than 3 minutes, its hypotension.

The third stage is the time of the release of bile portion A. It begins from the moment the sphincter of Oddi opens and the appearance of light bile. Normally, 4-6 ml of bile flows out in 2-3 minutes (1-2 ml / min). A high rate is noted with hypotension, a smaller one with hypertension of the common bile duct and the sphincter of Oddi.

The fourth stage is the time of the release of the bile portion B. It begins from the moment the dark gallbladder bile is released due to the relaxation of the sphincter of Lutkens and the contraction of the gallbladder. Normally, about 22–44 ml of bile is secreted in 20–30 minutes, depending on age. If the emptying of the gallbladder is faster and the amount of bile is less than indicated, then there is reason to think about hypertonic-hyperkinetic dysfunction of the bladder, and if the emptying is slower and the amount of bile is greater than indicated, then this indicates hypotonic-hypokinetic dysfunction of the bladder, one of the reasons for which may be hypertension of the sphincter of Lutkens (with the exception of cases of atonic cholestasis, the final diagnosis of which is possible with ultrasound, cholecystography, radioisotope research).

The fifth stage is the time of release of the bile portion C. After the emptying of the gallbladder (the expiration of dark bile), the portion C bile (lighter than the bile A) is released, which is collected at 5-minute intervals for 15 minutes. Normally, bile portion C is secreted at a rate of 1-1.5 ml / min. To check the degree of emptying of the gallbladder, the stimulus is re-introduced, and if dark bile “goes” again (portion B), then the bladder has not completely contracted, which indicates hypertonic dyskinesia of the sphincter apparatus.

If it was not possible to obtain bile, then probing is carried out after 2-3 days against the background of preparing the patient with atropine and papaverine preparations. Immediately before probing, it is advisable to apply diathermy, faradization of the phrenic nerve. Microscopy of bile is carried out immediately after probing. Material for cytological examination can be stored for 1-2 hours by adding a 10% solution of neutral formalin to it (2 ml of a 10% solution per 10-20 ml of bile).

It is necessary to send all 3 portions of bile for sowing (A, B, C).

Microscopy of bile. Leukocytes in bile can be of oral, gastric and intestinal origin, therefore, with duodenal sounding, it is better to use a two-channel probe, which allows you to constantly suck out gastric contents. In addition, with unconditionally proven cholecystitis (during surgery in adults), in 50-60% of cases in the bile of portion B, the content of leukocytes is not increased. White blood cells in bile are now given relative importance in the diagnosis of cholecystitis.

In modern gastroenterology, diagnostic value is not attached to the detection of portion B of leukocytes and cell epithelium of the biliary tract in the bile. The most important criterion is the presence in portion B of microliths (accumulation of mucus, leukocytes and cellular epithelium), cholesterol crystals, lumps of bile acids and calcium bilirubinate, brown films - the deposition of mucus in bile on the wall of the gallbladder.

The presence of Giardia, opisthorchia can support various pathological (mainly inflammatory and dyskinetic) processes in the gastrointestinal tract. Giardia does not live in the gallbladder of healthy people, since bile causes their death. The bile of patients with cholecystitis does not have these properties: Giardia settle on the mucous membrane of the gallbladder and contribute (in combination with microbes) to maintaining the inflammatory process, dyskinesia.

Thus, Giardia cannot cause cholecystitis, but can cause the development of duodenitis, biliary dyskinesia, i.e. aggravate cholecystitis, contributing to its chronic course. If vegetative forms of giardia are found in the bile of a patient, then, depending on the clinical picture of the disease and the results of duodenal sounding, either chronic cholecystitis or biliary dyskinesia is made as the main diagnosis, and intestinal giardiasis as a concomitant.

Of the biochemical abnormalities of bile, the signs of cholecystitis are an increase in protein concentration, dysproteinocholia, an increase in the concentration of immunoglobulins G and A, C-reactive protein, alkaline phosphatase, bilirubin.

The results of probing should be interpreted taking into account the history and clinical picture of the disease. Diagnostic value for the detection of cervical cholecystitis has computed tomography.

In addition to those presented above, the following risk factors for the development of cholecystitis are distinguished: heredity; transferred viral hepatitis and infectious mononucleosis, sepsis, intestinal infections with a protracted course; giardiasis of the intestine; pancreatitis; malabsorption syndrome; obesity, obesity; sedentary lifestyle, combined with poor nutrition (in particular, the abuse of fatty foods, canned industrial products); hemolytic anemia; connection of pain in the right hypochondrium with the intake of fried, fatty foods; persisting for a year or more clinical and laboratory data indicating biliary dyskinesia (especially diagnosed as the only pathology); persistent subfebrile condition of unknown origin (with the exclusion of other foci of chronic infection in the nasopharynx, lungs, kidneys, as well as tuberculosis, helminthiases). The detection of typical "bubble symptoms" in a patient in combination with 3-4 of the above risk factors allows diagnosing cholecystopathy, cholecystitis or dyskinesia even without duodenal sounding. Ultrasound confirms the diagnosis.

Echographic (ultrasound) signs of chronic cholecystitis:

• diffuse thickening of the walls of the gallbladder more than 3 mm and its deformation;
• compaction and / or layering of the walls of the organ;
• a decrease in the volume of the organ cavity (shrunken gallbladder);
• "inhomogeneous" cavity of the gallbladder.

In many modern guidelines, ultrasound diagnostics is considered decisive in identifying the nature of the pathology of the gallbladder.

As already mentioned, biliary dyskinesia cannot be the main or only diagnosis. Long-term biliary dyskinesia inevitably leads to excessive contamination of the intestine, and that, in turn, to infection of the gallbladder, especially with hypotonic dyskinesia.

In chronic disease of the biliary tract, cholecystography is performed to exclude malformations of their development. An x-ray examination in patients with hypotonic dyskinesia shows an enlarged, expanding downward and often lowered gallbladder; its emptying is slow. There is hypotension of the stomach.

With hypertensive dyskinesia, the shadow of the gallbladder is reduced, intense, oval or spherical in shape, emptying is accelerated.

Instrumental and laboratory data

• Blood test during exacerbation: neutrophilic leukocytosis, accelerated ESR up to 15–20 mm/h, the appearance of C-reactive protein, an increase in α1- and γ-globulins, an increase in the activity of “liver spectrum” enzymes: aminotransferases, alkaline phosphatase, γ-glutamate dehydrogenase, and as well as the content of the level of total bilirubin.
• Duodenal sounding: take into account the time of appearance of portions and the amount of bile. When flakes of mucus, bilirubin, cholesterol are found, it is microscopically examined: the presence of leukocytes, bilibirubinates, giardia confirms the diagnosis. The presence of changes in portion B indicates a process in the bladder itself, and in portion C - a process in the bile ducts.
• Ultrasound of the hepatobiliary zone will detect a diffuse thickening of the gallbladder walls of more than 3 mm and its deformation, compaction and / or layering of the walls of this organ, a decrease in the volume of the gallbladder cavity (shrunken bladder), and an “inhomogeneous” cavity. In the presence of dyskinesia, there are no signs of inflammation, but the bladder will be greatly stretched and emptied poorly or very quickly.

The course of chronic cholecystitis can be recurrent, latent latent or in the form of attacks of hepatic colic.

With often recurrent cholecystitis, cholangitis may develop. This is an inflammation of the large intrahepatic ducts. The etiology is basically the same as in cholecystitis. Often accompanied by fever, sometimes chills, fever. The temperature is well tolerated, which is generally characteristic of colibacillary infection. Enlargement of the liver is characteristic, its edge becomes painful. Often there is yellowness associated with a deterioration in the outflow of bile due to blockage of the bile ducts with mucus, skin itching joins. In the study of blood - leukocytosis, accelerated ESR.

Treatment

With exacerbations of chronic cholecystitis, patients are hospitalized in surgical or therapeutic hospitals and treatment is carried out, as in acute cholecystitis. In mild cases, outpatient treatment is possible. Assign bed rest, diet food (diet No. 5a) with meals 4-6 times a day.

To eliminate biliary dyskinesia, spastic pain, improve bile flow, symptomatic therapy is prescribed with one of the following drugs.

Selective myotropic antispasmodics: mebeverine (duspatalin) 200 mg 2 times a day (morning and evening, treatment course 14 days).

Prokinetics: cisapride (coordinax) 10 mg 3-4 times a day; domperidone (motilium) 10 mg 3-4 times a day; metoclopromide (cerucal, raglan) 10 mg 3 times a day.

Systemic myotropic antispasmodics: no-shpa (drotaverine) 40 mg 3 times a day; nikospan (no-shpa + vitamin PP) 100 mg 3 times a day.

M- anticholinergics: buscopan (hyocynabutyl bromide) 10 mg 2 times a day.

Comparative characteristics systemic and selective antispasmodics is reflected in table 2.

Advantages of the selective antispasmodic mebeverine (Duspatalin)

• Duspatalin has a dual mechanism of action: it eliminates spasm and does not cause intestinal atony.
• It acts directly on the smooth muscle cell, which, due to the complexity of the nervous regulation of the intestine, is preferable and allows you to get a predictable clinical result.
• Does not act on the cholinergic system and therefore does not cause side effects such as dry mouth, blurred vision, tachycardia, urinary retention, constipation and weakness.
• Can be prescribed to patients suffering from prostatic hypertrophy.
• Selectively acts on the intestines and biliary tract.
• There are no systemic effects: the entire administered dose is completely metabolized when passing through the intestinal wall and liver to inactive metabolites, and mebeverine is not detected in plasma in the blood.
• Extensive clinical experience.
• In the presence of bile reflux into the stomach, antacids are recommended in 1 dose 1.5-2 hours after a meal: maalox (algeldrate + magnesium hydrochloride), phosphalugel (aluminum phosphate).

Violations of the outflow of bile in patients with chronic cholecystitis are corrected by choleretic drugs. There are choleretic agents of choleretic action, which stimulate the formation and secretion of bile by the liver, and cholekinetic drugs that increase the muscle contraction of the gallbladder and the flow of bile into the duodenum.

Choleretic drugs:

• oxafenamide, tsikvalon, nikodin - synthetic agents;
• chophytol, allochol, tanacehol, tykveol, cholenzim, lyobil, flamin, immortelle, cholagon, odeston, hepatofalk planta, hepabene, herbion choleretic drops, corn stigmas - of plant origin;
• festal, digestal, kotazim - enzyme preparations containing bile acids.

Cholekinetic drugs: cholecystokinin, magnesium sulfate, sorbitol, xylitol, Karlovy Vary salt, sea buckthorn and olive oil.

Choleretic drugs can be used in the main forms of cholecystitis, in the phases of subsiding exacerbation or remission, they are usually prescribed for 3 weeks, then it is advisable to change the drug.

Cholekinetics should not be prescribed to patients with calculous cholecystitis, they are indicated for patients with non-calculous cholecystitis with hypomotor dyskinesia of the gallbladder. Effective in patients with non-calculous cholecystitis therapeutic duodenal sounding, 5-6 times a day, especially with hypomotor dyskinesia. In the remission phase, such patients should be recommended "blind duodenal sounding" once a week or 2 weeks. For their implementation, it is better to use xylitol and sorbitol. Patients with calculous cholecystitis duodenal soundings are contraindicated because of the risk of developing obstructive jaundice.

Patients with non-calculous cholecystitis with impaired physicochemical properties of bile (dyskrinia) are shown to be prescribed for a long period of time (3-6 months) wheat bran, enterosorbents (enterosgel 15 g 3 times a day).

Diet: restriction of fatty foods, restriction of high-calorie foods, exclusion of poorly tolerated foods. Regular 4-5 meals a day.

With the failure of conservative treatment and frequent exacerbations, surgical intervention is necessary.

Prevention of chronic cholecystitis consists in observing the diet, playing sports, physical education, preventing obesity, and treating focal infection.

For literature inquiries, please contact the editor.

T. E. Polunina, Doctor of Medical Sciences E. V. Polunina "Guta-Clinic", Moscow

www.lvrach.ru

• Careful history taking and physical examination (identification of typical signs of biliary colic, symptoms of an inflamed gallbladder).
• Conducting ultrasound as a priority method or other studies that allow the visualization of gallstones. However, even if stones are not detected by available methods, the likelihood of their presence in the common bile duct is assessed as high if the following clinical and laboratory signs are present: jaundice; expansion of the bile ducts, including intrahepatic, according to ultrasound; altered liver tests (total bilirubin, ALT, ACT, gamma-glutamyl transpeptidase, alkaline phosphatase, the latter increases when cholestasis occurs due to obstruction of the common bile duct).
• Laboratory research is necessary to detect persistent obstruction of the biliary tract or the addition of acute cholecystitis.

Laboratory research

For uncomplicated cholelithiasis, changes in laboratory parameters are not typical.

With the development of acute cholecystitis and concomitant cholangitis, leukocytosis (11-15x109 / l), an increase in ESR, an increase in the activity of serum aminotransferases, cholestasis enzymes - alkaline phosphatase, y-glutamyl transpeptidase (GGTP), bilirubin levels up to 51-120 μmol / l (3- 7 mg%).

Mandatory laboratory tests

• general clinical studies: clinical blood test. Leukocytosis with a shift of the leukocyte formula to the left is not characteristic of biliary colic. It usually occurs when acute cholecystitis or cholangitis is attached; reticulocytes;
• coprogram;
• general urine analysis;
• plasma glucose
• Indicators of lipid metabolism: total blood cholesterol, low density lipoproteins, very low density lipoproteins.
• Liver function tests (their increase is associated with choledocholithiasis and obstruction of the biliary tract): ACT; ALT; y-glutamyl transpeptidase; prothrombin index; alkaline phosphatase; bilirubin: total, direct, serum albumin;
• Pancreatic enzymes: blood amylase, amylase.

• Hepatitis virus markers:

Instrumental Research

If there is a clinically justified suspicion of cholelithiasis, an ultrasound scan is necessary in the first place.

The diagnosis of cholelithiasis is confirmed using computed tomography (gall bladder, bile ducts, liver, pancreas) with a quantitative determination of the coefficient of attenuation of gallstones according to Hounsfield (the method allows you to indirectly judge the composition of calculi by their density), magnetic resonance cholangiopancreatography (allows you to identify invisible when Ultrasound of stones in the bile ducts, sensitivity 92%, specificity 97%), ERCP (a highly informative method for studying the extrahepatic ducts in case of suspicion of a common bile duct stone or to exclude other diseases and causes of obstructive jaundice).

Mandatory instrumental studies

• Ultrasound of the abdominal organs is the most accessible method with

  high rates of sensitivity and specificity for the detection of gallstones: for stones in the gallbladder and cystic duct, the sensitivity of ultrasound is 89%, the specificity is 97%; for stones in the common bile duct, the sensitivity is less than 50%, the specificity is 95%. A targeted search is needed: expansion of the intra- and extrahepatic bile ducts; stones in the lumen of the gallbladder and bile ducts; signs of acute cholecystitis in the form of a thickening of the gallbladder wall more than 4 mm and the identification of a "double contour" of the gallbladder wall.

• Plain radiography of the gallbladder area: the sensitivity of the method for the detection of gallstones is less than 20% due to their frequent radionegativity.
• FEGDS: performed to assess the condition of the stomach and duodenum, examination of the major duodenal papilla in case of suspected choledocholithiasis.

• Biliary sludge: sometimes a typical clinical picture of biliary colic is observed. The presence of a gallbladder in the gallbladder on ultrasound is characteristic.
• Functional diseases of the gallbladder and biliary tract: no stones are found during the examination, signs of impaired contractility of the gallbladder (hypo- or hyperkinesia), spasm of the sphincter apparatus according to direct manometry (dysfunction of the sphincter of Oddi) are found. Pathologies of the esophagus: esophagitis, esophagospasm, hiatal hernia. Characterized by pain in the epigastric region and behind the sternum, in combination with typical changes in FEGDS or X-ray examination of the upper gastrointestinal tract.
• Peptic ulcer of the stomach and duodenum. Pain in the epigastric region is characteristic, sometimes radiating to the back and decreasing after eating, taking antacids and antisecretory drugs. It is necessary to carry out FEGDS.
• Pancreatic diseases: acute and chronic pancreatitis, pseudocysts, tumors. Typical pain in the epigastric region, radiating to the back, provoked by eating and often accompanied by vomiting. The diagnosis is helped by the detection of increased activity in the blood serum of amylase and lipase, as well as typical changes according to the results of radiological diagnostic methods. It should be borne in mind that cholelithiasis and biliary sludge can lead to the development of acute pancreatitis.
• Liver disease: characterized by dull pain in the right hypochondrium, radiating to the back and right shoulder blade. The pain is usually constant (which is not typical for pain in biliary

  colic) and is accompanied by enlargement and soreness of the liver

  on palpation. The diagnosis is helped by the determination of blood enzymes of the liver, markers of acute hepatitis and imaging studies.

• Colon diseases: irritable bowel syndrome, inflammatory lesions (especially when the hepatic flexure of the colon is involved in the pathological process). Pain syndrome is often caused by motor disorders. The pain often improves after a bowel movement or passing flatus. Colonoscopy or barium enema can distinguish between functional and organic changes.
• Diseases of the lungs and pleura. Symptoms of pleurisy are characteristic, often associated with cough and shortness of breath. A chest x-ray is required.
• Pathology of skeletal muscles. There may be pain in the right upper quadrant of the abdomen associated with movements or the adoption of a certain position. Palpation of the ribs may be painful; increased pain is possible with tension in the muscles of the anterior abdominal wall.

Indications for hospitalization

To the surgical hospital:

• recurrent biliary colic;
• acute and chronic cholecystitis and their complications;
• acute biliary pancreatitis.

• chronic calculous cholecystitis - for a detailed examination and preparation for surgical or conservative treatment;
• exacerbation of cholelithiasis and condition after cholecystectomy (chronic biliary pancreatitis, dysfunction of the sphincter of Oddi).

Non-drug treatment

Diet therapy: at all stages, 4-6 meals a day are recommended with the exception of foods that increase bile secretion, secretion of the stomach and pancreas. Exclude smoked products, refractory fats, irritating seasonings. The diet should include a large amount of vegetable fiber with the addition of bran, which not only normalizes intestinal motility, but also reduces the lithogenicity of bile. With biliary colic, fasting is necessary for 2-3 days.

Drug therapy

Oral litholytic therapy is the only effective conservative treatment for cholelithiasis. To dissolve stones, bile acid preparations are used: ursodeoxycholic acid (Ursofalk, Ursosan) and chenodeoxycholic acid. Ursodeoxycholic acid slows down the absorption of cholesterol in the intestine and promotes the transition of cholesterol from stones to bile. Chenodeoxycholic acid inhibits the synthesis of cholesterol in the liver and also helps to dissolve cholesterol stones. Treatment with bile acid preparations is carried out and monitored on an outpatient basis. Rigid selection criteria for patients make this method available to a very small group of patients with an uncomplicated course of the disease - approximately 15% with cholelithiasis. The high cost also limits the application of this method. The most favorable conditions for the outcome of oral lithotripsy are:

• in the early stages of the disease;

• with uncomplicated cholelithiasis, rare episodes of biliary colic, moderate pain syndrome;
• in the presence of pure cholesterol stones (“float” during 3 oral cholecystography);
• in the presence of non-calcified stones in the bladder (attenuation coefficient at CT less than 70 Hounsfield units);

1. Complicated cholelithiasis, including acute and chronic cholecystitis, as the patient is shown rapid sanitation of the biliary tract and cholecystectomy.
2. Disabled gallbladder.
3. Frequent episodes of biliary colic.
4. Pregnancy.
5. Severe obesity.
6. Open ulcer of the stomach or duodenum.
7. Concomitant liver diseases - acute and chronic hepatitis, cirrhosis of the liver.
8. Chronic diarrhea.
9. Gallbladder carcinoma.

1. The presence of pigmented and calcified cholesterol stones in the gallbladder.
2. Stones with a diameter of more than 15 mm.
3. Multiple stones occupying more than 50% of the gallbladder lumen.

Antibacterial therapy. It is indicated for acute cholecystitis and cholangitis (see the article "chronic acalculous cholecystitis").

Surgery

With asymptomatic cholelithiasis, as well as with a single episode of biliary colic and infrequent pain episodes, expectant tactics are most justified. If there are indications in these cases, it is possible to perform oral lithotripsy. Indications for surgical treatment for cholecystolithiasis:

■ the presence of large and small stones in the gallbladder, occupying more than "/3 ​​of its volume;

• the course of the disease with frequent attacks of biliary colic, regardless of the size of the stones;

• disabled gallbladder;
• cholelithiasis complicated by cholecystitis and/or cholangitis;
• combination with choledocholithiasis;
• cholelithiasis, complicated by the development of Mirizzi's syndrome;
• cholelithiasis, complicated by dropsy, empyema of the gallbladder; cholelithiasis complicated by perforation, penetration, fistulas;
• cholelithiasis complicated by biliary pancreatitis;
• cholelithiasis, accompanied by impaired patency of the general

• Cholecystectomy. It is not indicated for asymptomatic stone carriers, since the risk of surgery outweighs the risk of developing symptoms or complications. However, in some cases, laparoscopic cholecystectomy is considered justified even in the absence of clinical manifestations (Indications for cholecystectomy in asymptomatic stone carriers are a calcified “porcelain” gallbladder; stones larger than 3 cm; upcoming long stay in a region with a lack of qualified medical care; sickle cell anemia the patient's upcoming organ transplant).

The effectiveness of conservative treatment is quite high: with proper selection of patients, complete dissolution of stones is observed after 18-24 months in 60-70% of patients, but relapses of the disease are not uncommon.

Literature

1. Practical hepatology \under. Ed. N.A. Mukhina - Moscow, 2004.- 294 P.
2. Vetshev P.S. Cholelithiasis and cholecystitis // Clinical perspectives of gastroenterology, hepatology.- 2005.- No. 1- C 16-24.
3. Peter R., McNally "Secrets of gastroenterology", Moscow, 2004.
4. Lychev V.G. "Fundamentals of Clinical Gastroenterology", Moscow, N-Novgorod, 2005
5. Gastroenterology (clinical guidelines) //Pod. ed. V.T.Ivashkina.- M.: "GEOTAR-Media", 2008.- P.83-91

CHRONIC ASCALTLESS CHOLECYSTITIS (CBC)

DEFINITION. Chronic acalculous cholecystitis is a chronic recurrent inflammation of the gallbladder wall, accompanied by a violation of its motor-tonic function.

In the ICD 10 revision, cholecystitis occupies heading K 81

ETIOLOGY AND PATHOGENESIS

The leading role in the development of chronic cholecystitis is played by infection, the causative agent of infection usually enters by hematogenous and lymphogenous routes, less often by ascending, i.e. from the duodenum. The development of toxic and allergic inflammation in the gallbladder is observed. It is also possible that the wall of the gallbladder is damaged by pancreatic enzymes that get there due to an increase in pressure in the ampulla of the common bile duct. Such forms of cholecystitis are enzymatic.

topuch.ru

Antihelicobacter peptic ulcer therapy

Modern approaches to the diagnosis and treatment of N.R. infection, which meet the principles of evidence-based medicine, are reflected in the final document of the conference in Maastricht-3 (2005) - see Table. Indications for eradication treatment remained unchanged compared to Maastricht-2 (2000)

Who to treat: indications that meet the “highly recommended” level

Peptic ulcer of the duodenum / stomach (in the stage of exacerbation or remission, including complicated PU)

Atrophic gastritis

Condition after gastric resection for cancer

Eradication of H.P. in persons who are close relatives of patients with gastric cancer

Eradication of H.P. can be performed at the request of the patient

The first 3 readings are indisputable

Table 1. Eradication therapy regimens (Maastricht 3, 2005)

The 2005 Maastricht-3 consensus concludes that a 14-day course is 10-12% more effective than a 7-day course. The use of the latter (cheaper) is acceptable in countries with low levels of health care if it gives good results in that region. For triple therapy (first-line therapy), only two pairs of antibacterial agents are offered - clarithromycin (1000 mg / day) and amoxicillin (2000 mg / day) or metronidazole (1000 mg / day) while taking PPIs at a standard dose.

The combination of clarithromycin and amoxicillin is preferred. In case of failure, quadruple therapy (second-line therapy) should be carried out - PPI, bismuth subsalicylate / subcitrate, metronidazole, tetracycline. Thus, the therapy of choice for H.R.-associated PU is eradication treatment.

If it is not possible to use it, an alternative use of the combination is allowed: since no resistant strains of Hp have been developed against amoxicillin during its use, it is possible to prescribe its high doses of 750 mg 4 times a day for 14 days in combination with high doses of PPI 20 mg 4 times per day Another option may be to replace metronidazole in quadruple therapy with furazolidone 100-200 mg 2 times a day. An alternative regimen is the combination of a PPI with amoxicillin and rifabutin (300 mg daily) or levofloxacin (500 mg daily). Or a sequential regimen of rabeprazole 40 mg daily and amoxicillin (2 g daily) for 5 days followed by clarithromycin (500 mg twice daily) also for 5 days. The latter regimen, according to 4 Italian randomized trials, is more effective than the 7-day eradication regimen. Of the IPPs, the most effective drug considered parity. Pariet (rabeprazole) 7-day regimens were more effective than omeprazole 10-day regimens. In conclusion, the suggestion was made to use antibiotic susceptibility-based therapy in cases where two successive H. pylori eradication courses have failed.

Treatment outcome requirements include complete remission with two negative tests for H.R. (carried out not earlier than 4 weeks after the withdrawal of drug treatment).

After the end of combined eradication therapy, it is recommended to continue treatment for another 5 weeks with duodenal and 7 weeks with gastric localization of ulcers using PPIs.

With N.R. - an independent form of PU, the main method of therapy is the appointment of PPIs. The following drugs are used:

rabeprazole at a dose of 20 mg / day;

omeprazole at a dose of 20-40 mg / day;

esomeprazole at a dose of 40 mg / day;

lansoprazole at a dose of 30-60 mg / day;

pantoprazole at a dose of 40 mg / day.

The duration of the course of treatment is usually 2-4 weeks, if necessary - 8 weeks (until the symptoms disappear and the ulcer heals).

Indications for continuous treatment (for months and years) are:

The ineffectiveness of the therapy.

Incomplete remission with adequate therapy, especially in young people and with newly diagnosed ulcers.

Complicated peptic ulcer.

The presence of concomitant diseases requiring the use of NSAIDs.

Associated GERD

Patients over 60 years of age with annual exacerbations with adequate course treatment.

Continuous maintenance therapy consists of half dose PPIs.

If a dispensary patient with PU has no exacerbations for 3 years and is in a state of complete remission, then such a patient is subject to removal from the dispensary register and, as a rule, does not need treatment for PU.

The protocol of eradication therapy implies mandatory monitoring of its effectiveness, which is carried out 4-6 weeks after the end of taking antibacterial drugs and proton pump inhibitors (see the section "Diagnosis of the result of H. pylori eradication therapy"). The best method for diagnosing H. pylori infection on this stage- a breath test, but if it is not available, other diagnostic methods can be used.

Surgery

Indications for surgical treatment of peptic ulcer are complications of this disease:

perforation;

bleeding;

stenosis with severe evacuation disorders.

When choosing a method of surgical treatment, preference is given to organ-preserving operations (vagotomy with draining operations).

The prognosis is favorable for uncomplicated peptic ulcer disease. In the case of successful eradication, relapses of peptic ulcer during the first year occur in 6-7% of patients. The prognosis worsens with a long prescription of the disease in combination with frequent, prolonged relapses, with complicated forms of peptic ulcer.

Literature

Maev I.V., Samsonov A.A. Modern standards for the treatment of acid-dependent diseases associated with H. Pylori (maastricht-3 consensus materials) // Gastroenterology. - 2006. - No. 1 -С 3-8.

Yakovenko A.V., Grigoriev P.Ya., Yakovenko E.P., Agafonova N.A., Pryanishnikova A.S., Ivanova A.N., Aldiyarova M.A., Soluyanova I.P., Anashkin V. A., Oprishchenko I.V. Cytoprotectors in the treatment of stomach diseases. Optimal approach to the choice of drug // Gastroenterology. - 2006. - No. 2 -С 1-4.

de Leest H, Steen K, Lems W et al. Eradication of Helicobacter pylori bas no beneficial effect for prevention of peptic ulcers in patients with long – term NSAID treatment: a randomized, double blind placebo controlled trail. Gastroenterol 2004; 126:611.

Anaeva T.M., Grigoriev P.Ya., Komleva Yu.V., Aldiyarova M.A., Yakrvenko A.V., Anashkin V.A., Khasabov N.N., Yakovenko E.P. The role of cytokines in the pathogenesis of diseases of the stomach and duodenum associated with Helicobacter pylori infection and issues of therapy // Practitioner. - 2004. - No. 1 -С 27-30.

Grigoriev P.Ya., Pryanishnikova A.S., Soluyanova I.P. progress in the diagnosis and treatment of Helicobacter pylori infection and associated diseases (gastritis, gastroduodenitis, peptic ulcer and their complications) // Practitioner. - 2004. - No. 1 -С 30-32.

Maev I.V., Samsonov A.A., Nikushkina I.N. Diagnosis, treatment and prevention of acute gastrointestinal bleeding // Farmateka. - 2005. - No. 1 - C 62-67.

Khomeriki N.M., Khomeriki S.G. Four-component regimens for the treatment of Helicobacter pylori infection: eradication without sanction // Pharmateka .. - 2004. - No. 13 - C 19-22.

Khomeriki N.M., Khomeriki S.G. Influence of antisecretory and antacid agents on the sensitivity of the urease test in the diagnosis of Helicobacter pylori infection // Farmateka .. - 2003. - No. 10 - C 57-60.

CHRONIC PANCREATITIS

DEFINITION. Chronic pancreatitis (CP) is a chronic progressive disease of the pancreas, predominantly of an inflammatory nature, leading to the development of exo- and endocrine insufficiency of the gland function.

In ICD-10, CP occupies the following headings: K86.0 Chronic pancreatitis of alcoholic etiology K86.1 Other chronic pancreatitis.

The diagnosis of CP according to the Marseilles-Rome classification (1989) requires a morphological study of the pancreas and endoscopic retrograde cholangiopancreatography, which is not always available. When making a diagnosis, it is possible to indicate the etiology of the disease. The incidence of CP is 4-8 cases per 100,000 population per year, the prevalence in Europe is 0.25%. Mortality on average in the world is 11.9%. Epidemiological, clinical and pathoanatomical studies indicate that over the past 30 years there has been a twofold increase in the number of patients with acute and chronic pancreatitis in the world. This is associated with an increase in alcoholism, an increase in diseases of the region of the major duodenal papilla.

ETIOLOGY AND PATHOGENESIS

Among the many causes of CP, alcoholism accounts for 40-90% of cases. It was found that under the influence of alcohol, the qualitative composition of pancreatic juice changes, which contains an excess amount of protein and a low concentration of bicarbonates. This ratio contributes to the precipitation of protein precipitates in the form of plugs, which then calcify and obturate the pancreatic ducts. In addition, alcohol and its metabolites have a direct toxic effect, lead to the formation of free radicals responsible for the development of necrosis and inflammation.

Among the causative factors of CP, biliary tract pathology occurs in 35-56% of cases. This variant of HP is based on the common duct theory. Due to the anatomical proximity of the places where the bile and pancreatic ducts enter the duodenum, with an increase in pressure in the biliary system, bile reflux into the pancreatic ducts can occur, which in turn leads to damage to the pancreas by detergents contained in bile.

Drug-induced pancreatitis occurs in about 2% of cases. Drugs that have repeatedly caused the development of acute pancreatitis include aminosalicylates, calcium, thiazide diuretics, valproic acid (confirmed data), azathioprine, cyclosporine, erythromycin, metronidazole, mercaptopurine, paracetamol, rifampicin, sulfonamides (controversial data), drugs, intake which induces the development of CP - thiazide diuretics, tetracyclines, sulfasalazine, estrogens.

Hereditary pancreatitis occurs in 1-3% of cases. There is evidence that in young patients with CP, with a family predisposition to pancreatic diseases, there is a special gene mutation in the arm of the 7th chromosome (7g35), resulting in a change in the trypsin molecule, which makes it more resistant to destruction by certain proteins. and causes a violation of the mechanisms of protection against intracellular trypsin activation.

Can you eat eggs after gallbladder removal?

RCHD (Republican Center for Health Development of the Ministry of Health of the Republic of Kazakhstan)
Version: Archive - Clinical Protocols of the Ministry of Health of the Republic of Kazakhstan - 2010 (Order No. 239)

Chronic cholecystitis (K81.1)

general information

Short description

Chronic cholecystitis- This is a chronic inflammatory lesion of the gallbladder wall with its gradual sclerosis and deformation.

Protocol"Cholecystitis"

ICD-10 codes:

K 81.1 Chronic cholecystitis

K 83.0 Cholangitis

K83.8 Other specified diseases of biliary tract

K83.9 Disease of biliary tract, unspecified

Classification

1. Downstream: acute, chronic, recurrent.

2. By the nature of inflammation: catarrhal, phlegmonous, gangrenous.

3. According to the phase of the disease: exacerbations, incomplete remission, remission.

Diagnostics

Diagnostic criteria

Complaints and anamnesis: dull paroxysmal pain in the right upper quadrant (especially after fatty and fried foods, spicy foods, carbonated drinks) in combination with dyspeptic disorders (bitterness in the mouth, vomiting, belching, loss of appetite), constipation or unstable stools, dermatitis, headache, weakness , fatigue.

Physical examination: muscle resistance in the right hypochondrium, positive "vesical" symptoms: Kerr (pain at the point of the gallbladder), Ortner (pain with an oblique blow to the right hypochondrium), Murphy (sharp pain on inspiration with deep palpation in the right hypochondrium), pain on palpation of the right hypochondrium, symptoms of moderately severe chronic intoxication.

Laboratory research: KLA (may be an increase in ESR, moderate leukocytosis).

Instrumental research: on ultrasound - compaction and thickening of the gallbladder over 2 mm, an increase in its size by more than 5 mm 2 from the upper limit of normal, the presence of paravisical echonegativity, sludge syndrome (International criteria for inflammation of the gallbladder, Vienna, 1998).

Indications for expert advice:

Dentist;

Physiotherapist;

Physical therapy doctor.

List of main diagnostic measures:

2. Complete blood count (6 parameters).

3. General analysis of urine.

4. Definition of AST.

5. Definition of ALT.

6. Determination of bilirubin.

7. Examination of feces for scatology.

8. Duodenal sounding.

9. Bacteriological analysis of bile.

11. Dentist.

12. Physiotherapist.

13. Physical therapy doctor.

List of additional diagnostic measures:

1. Esophagogastroduodenoscopy.

2. Cholecystocholangiography.

3. Definition of diastase.

4. Determination of blood glucose.

5. Determination of alkaline phosphatase.

6. Determination of cholesterol.

7. Cholangiopancreatography (computed, magnetic resonance imaging).

8. Retrograde cholangiopancreatography.

9. Electrocardiography.

Differential Diagnosis

Treatment abroad

Get treatment in Korea, Israel, Germany, USA

Get advice on medical tourism

Treatment

Purpose of treatment:

Correction of motor disorders;

Relief of pain and dyspeptic syndromes.

Tactics:

1. Diet therapy.

2. Anti-inflammatory therapy.

3. Metabolic therapy.

4. Correction of motor disorders.

5. Cholagogue therapy.

Non-drug treatment

The diet includes an increase in food intake up to 4-6 times a day. The daily calorie content of the diet corresponds to the calorie content for a healthy child. In the hospital, the patient receives table No. 5 according to Pevzner.

Medical therapy

To eliminate bile infection, broad-spectrum antibacterial drugs are used, which are involved in enteropathic circulation and accumulate in therapeutic concentrations in the gallbladder. The drugs of choice are co-trimaxazole 240-480 mg 2 times a day.

Oral ciprofloxacin 250-500 mg 2 times a day, ampicillin trihydrate 250-500 mg 2 times a day, erythromycin 200-400 mg / day can also be prescribed. every 6 hours, furazolidone 10 mg / kg / day. in 3 doses or metronidazole 125-500 mg / day, in 2-3 doses. The appointment of the last two drugs is especially advisable in the detection of giardiasis.

Therapy with antibacterial agents is carried out, on average, for 8-10 days. However, taking into account the microflora isolated from bile and its sensitivity, treatment can be extended or changed.

Symptomatic drug therapy is used according to indications:

To normalize the motor function of the biliary tract, prokinetics are recommended - domperidone at 0.25-1.0 mg / kg 3-4 times a day, for 20-30 minutes. before meals, the duration of the course is 3 weeks;

Choleretic - silymarin with fumarin 1-2 capsules 3 times a day before meals or phenipentol, or magnesium sulfate, course duration is at least 3 weeks, chemical choleretics - oxyphenamide (or other drugs that increase choleresis and cholekinesis), course duration is at least 3 -x weeks;

In case of excretory insufficiency of the pancreas, pancreatin is prescribed at 10,000 units for lipase x 3 times with meals, for 2 weeks;

Algeldrate + magnesium hydroxide, (or other non-absorbable antacid) in one dose 1.5-2 hours after a meal.

During an attack of biliary colic, it is important to eliminate the pain syndrome as soon as possible. For this purpose, they appoint - no-shpu 1 t. x 3 r. in the village, buscopan 1 t. x 3 p. in e. If taking drugs inside does not relieve an attack, then intramuscularly injected 0.2% solution of platyfillin, 1% solution of papaverine.

Patients need dispensary observation, as well as rehabilitation of chronic foci of infection, because. 40% of patients suffer from chronic tonsillitis, helminthic invasion and giardiasis.

Preventive actions:

1. Prevention of infectious complications.

2. Prevention of the formation of gallstone disease.

Further management

It is necessary to follow a diet after suffering an exacerbation of cholecystitis for 3 years. The transition to a common table should be gradual. Courses of specific treatment (choleretic therapy) should be carried out after discharge from the hospital in the first year 4 times (after 1,3,6, 12 months), and in the next 2 years 2 times a year. The course of treatment lasts 1 month. and includes the appointment of cholekinetics and choleretics.

List of essential medicines:

1. Ampicillin trihydrate, 250 mg, tab.; 250 mg, 500 mg capsule, 500 mg, 1000 mg powder for injection, 125/5 ml suspension in vial

2. Erythromycin, 250 mg, 500 mg tab.; 250 mg/5 ml oral suspension

3. Furazolidone, 0.5 mg tab.

4. Ornidazole, 250 mg, 500 mg tab.

5. Metronidazole, 250 mg, 0.5 vial solution for infusion

6. Intraconazole, oral solution 150 ml - 10 mg/ml

7. Domperidone, 10 mg tab.

8. Fumarin, caps.

9. Magnesium sulfate 25% - 20 ml amp.

10. Pancreatin, 4500 IU caps.

11. Algeldrate + magnesium hydroxide, 15 ml pack.

12. Co-trimaxazole, 240 mg, 480 mg tab.

13. Pirantel, 250 mg tab.; 125 mg oral suspension

14. Mebendazole 100 mg chewable tablet

List of additional medicines:

1. Oxafenamide 250 mg, tab.

2. Ciprofloxacin 250 mg, 500 mg tab.; 200 mg/100 ml in vial, solution for infusion

3. Ursodeoxycholic acid 250 mg, caps.

4. Selymarin, caps.

5. Gepabene, caps.

6. Aevit, caps.

7. Pyridoxine hydrochloride 5%, 1.0 amp.

8. Thiamine bromide 5%, 10 amp.

Treatment effectiveness indicators:

Removal of exacerbation of the disease;

Relief of pain and dyspeptic syndromes.

Hospitalization

Indications for hospitalization (planned):

Severe pain syndrome and dyspepsia;

Frequent (more than 3 times a year) relapses.

The required amount of research before planned hospitalization:

1. Ultrasound of the abdominal organs.

3. ALT, AST, bilirubin.

4. Coprogram, scraping for enterobiasis.

Information

Sources and literature

1. Protocols for the diagnosis and treatment of diseases of the Ministry of Health of the Republic of Kazakhstan (Order No. 239 of 04/07/2010)
   1. 1. Clinical guidelines based on evidence-based medicine: Per. from English. / Ed. I.N. Denisova, V.I. Kulakova, R.M. Khaitova. - M.: GEOTAR-MED, 2001. - 1248 p.: ill. 2. Clinical guidelines + pharmacological guide: Ed. I.N.Denisova, Yu.L. Shevchenko - M.: GEOTAR-MED, 2004. - 1184 p.: ill. (Evidence Based Medicine series) 3.Society of Nuclear Medicine Procedure Guideline for Hepatobiliary Scintigraphyversion 3.0, approved June 23, 2001SOCIETY OF NUCLEAR MEDICINE PROCEDURE GUIDELINES MANUAL MARCH 2003. 4.EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES ON THE DIAGNOSIS AND TREATMENT OF CHOLECYSTITIS Domingo S. Bongala, Jr., MD, FPCS, Committee on Surgical Infections, Philippine College of Surgeons, Epifanio de los Santos Avenue, Quezon City, Philippines 5. Diseases of older children, a guide for physicians, R.R. Shilyaev et al., M, 2002. 6. Practical gastroenterology for a pediatrician, V.N. Preobrazhensky, Almaty, 1999. 7. Practical gastroenterology for a pediatrician, M.Yu. Denisov, M. 2004.

Information

List of developers:

1. Head of the Department of Gastroenterology, RCCH "Aksay", F.T. Kipshakbaeva.

2. Assistant of the Department of Children's Diseases KazNMU named after. S.D. Asfendiyarova, Ph.D., S.V. Choi.

3. Doctor of the Department of Gastroenterology of the RCCH "Aksai" V.N. Sologub.

Attached files

Attention!

• By self-medicating, you can cause irreparable harm to your health.
• The information posted on the MedElement website and in the mobile applications "MedElement (MedElement)", "Lekar Pro", "Dariger Pro", "Diseases: Therapist's Handbook" cannot and should not replace an in-person consultation with a doctor. Be sure to contact medical facilities if you have any diseases or symptoms that bother you.
• The choice of drugs and their dosage should be discussed with a specialist. Only a doctor can prescribe the right medicine and its dosage, taking into account the disease and the condition of the patient's body.
• The MedElement website and mobile applications "MedElement (MedElement)", "Lekar Pro", "Dariger Pro", "Diseases: Therapist's Handbook" are exclusively information and reference resources. The information posted on this site should not be used to arbitrarily change the doctor's prescriptions.
• The editors of MedElement are not responsible for any damage to health or material damage resulting from the use of this site.

MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS

BELARUSIAN STATE MEDICAL UNIVERSITY

1st DEPARTMENT OF SURGICAL DISEASES

S.I. Leonovich, A.I. Protasevich

CHOLELITHIASIS.

ACUTE AND CHRONIC
CALCULOSIS CHOLECYSTITIS

Reviewers: head. 2nd department surgical diseases, Dr. med. sciences, prof.
S.I. Tretyak; early cafe of military field surgery, BSMU, Ph.D. honey. Sciences, Assoc.
S.A. Zhidkov

Approved by the Scientific and Methodological Council of the University
as methodological recommendations 06/09/2004, protocol No. 8

Leonovich S.I.

L 47 Gallstone disease. Acute and chronic calculous cholecystitis: Method. recommendations / S.I. Leonovich, A.I. Protasevich - Minsk: BSMU, 2004. - 42 p.

The main theoretical issues related to gallstone disease are reflected. The etiology, pathogenesis, pathology and clinical picture of cholelithiasis and its complications are covered. Modern methods of diagnostics and treatment are presented.

UDC 616.366-033.7-036.11/.12(075.8)

BBC 54.13ya73

© Design. Belarusian state
medical university, 2004

Topic of the lesson: Cholelithiasis. CHRONIC AND ACUTE CALCULOSIS CHOLECYSTITIS

Total lesson time: 5 o'clock.

Motivational characteristic of the topic. Gallstone disease (GSD) and its complications are of considerable theoretical and practical interest to doctors of various specialties. Treatment of cholelithiasis is still the prerogative of surgeons, however, a number of situations require a common solution involving therapists, endoscopists, radiologists and other specialists.

According to the National Institutes of Health, cholelithiasis affects 10-15% of the adult population in the world. The emergence of new technologies in the diagnosis and treatment of this pathology require the physician to constantly improve their knowledge.

Lesson objectives: based on previously obtained data on normal and pathological anatomy, physiology and pathophysiology of the liver, gallbladder and bile ducts, to study the etiology, pathogenesis, clinic, diagnosis, treatment tactics for cholelithiasis and its complications.

Lesson objectives

Learn the normal and pathological anatomy of the gallbladder, bile ducts, sphincter of Oddi.

To get acquainted with the main etiological factors of cholelithiasis, to find out the pathogenesis of chronic acute calculous cholecystitis.

Learn the main clinical manifestations of cholelithiasis and its complications, learn how to collect anamnesis and complaints in this pathology.

Familiarize yourself with the principles of clinical examination of patients, learn how to diagnose various syndromes and symptoms in cholelithiasis.

Learn to evaluate the results of laboratory and instrumental diagnostic methods for chronic and acute calculous cholecystitis, choledocholithiasis, stenosis of the major duodenal papilla, cholangitis.

To master the treatment tactics and types of treatment of gallstone disease.

Requirements for the initial level of knowledge

For successful and complete mastering of the topic, it is necessary to repeat:

normal and topographic anatomy of the liver, gallbladder, bile ducts;

physiology of bile formation and bile secretion, synthesis and metabolism of cholesterol.

Control questions from related disciplines

Bile formation, principles, regulation of formation and secretion of bile.

What are the functions of the gallbladder?

What are the structure and functions of the choledochoduodenal junction (papilla of Vater, sphincter of Oddi)?

What is the morphological and functional relationship of the gallbladder, bile ducts, pancreas and duodenum?

Control questions on the topic of the lesson

Cholelithiasis. Concept, etiology, epidemiology, types of stones, pathogenesis.

Clinical manifestations of gallstone disease.

Laboratory and instrumental methods for the diagnosis of cholelithiasis, indications and evaluation of data.

Treatment of chronic calculous cholecystitis. Types of operations.

Treatment of acute calculous cholecystitis. Types of operations.

Alternative methods of treatment of cholelithiasis, types, indications for use.

Choledocholithiasis, concept, clinic, diagnosis, treatment options.

Stenosis of BSDK, concept, clinic, diagnostics and treatment.

Cholangitis, classification, pathogenesis, clinic, diagnosis, principles of treatment.

Mirizzi syndrome, concept, clinic, diagnosis, treatment.

Biliary fistulas, pathogenesis, clinic, diagnosis, treatment.

Methods of intraoperative examination of the bile ducts.

Gallbladder cancer, classification, clinical forms, clinic, diagnosis, treatment, prognosis.

EDUCATIONAL MATERIAL

Memorable dates from the history of biliary surgery

1867 - J.S. Bobbs - the first cholecystomy.

1882 - C. Langenbuch - the first planned cholecystectomy.

1882 - H. Marcy - the first choledocholithotomy.

1887 - N.D. Monastyrsky - the formation of cholecystojejunostomy.

1889 - Yu.F. Kosinsky - the first cholecystectomy in Russia.

1891 - R. Abbe - for the first time in the world performed external drainage of the common bile duct through the stump of the cystic duct.

1900 - W.S. Halsted - used hidden drainage to replace the defect of the common bile duct.

1931 - P.L. Mirizzi - proposed and performed the first intraoperative cholangiography.

1935 - P. Huard - for the first time used percutaneous transhepatic cholangiography.

1951 - H. Wilgegans - designed an endoscope for examining the choledochus (choledochoscopy).

1968 - McCune - introduction of endoscopic retrograde cholangiopancreatography into practice.

1974 - Nakajima M., Kawai K., Classen M. - introduction of endoscopic papillosphincterotomy into practice.

1984 - Ph. Mouret is the first video laparoscopic cholecystectomy.

Physiology of bile formation

Up to 1,000 ml of bile is continuously secreted in the liver daily. The main components of bile: water (hepatic bile - 98%, cystic bile - 84%), bile salts (hepatic bile - up to 1.4 g%, cystic bile - up to 11.5 g%), cholesterol (hepatic bile - up to 0, 2 g%, cystic - 1.6 g%), phospholipids (hepatic bile - 0.25 g%, cystic - 0.35 g%), bilirubin (hepatic bile - up to 140 mg%, cystic - up to 360 mg%) . The composition of bile also includes proteins, fatty acids, bicarbonates, electrolytes, mucin.

Cholesterol in bile is present in a free, non-esterified form; in the aqueous medium of bile, it can be transported only when vesicles or micelles are formed with bile acids and phospholipids.

Bile phospholipids are represented by lecithin (90%), lysolecithin (3%), phosphatidylethanolamine (1%). Phospholipids are hydrolyzed in the intestine and do not participate in the enterohepatic circulation.

The main part of bilirubin (up to 85%) is formed from erythrocyte hemoglobin, a smaller part is synthesized from hemoproteins of other tissues (myoglobin, cytochrome, catalase, etc.). Unconjugated bilirubin in plasma is bound to albumin, which transports it to hepatocytes. In a conjugation reaction, it turns into bilirubin mono- and diglucuronide (a water-soluble substance) and is excreted into bile. Bilirubin is not included in the enterohepatic circulation and, under the influence of enzymes in the large intestine, is converted into stercobilin and urobilinogen.

The bile acids are cholic and chenodeoxycholic acids (primary bile acids). They bind to glycine and taurine, decompose in the intestine to secondary bile acids - deoxycholic and lithocholic. Cholic, chenodeoxycholic, deoxycholic acids are absorbed in the intestine and enter the liver through the portal vein system, re-excreting into bile (enterohepatic circulation). Only 5–10% of bile acids are excreted in the feces. Bile acids perform the following functions in the body: the formation of micelles for the transport of water-insoluble substances (cholesterol, fat-soluble vitamins), the activation of pancreatic lipase, and the stimulation of intestinal motility.

Anatomy and physiology of the gallbladder

The gallbladder (GB) is a pear-shaped sac, 3 to 9 cm long, capable of holding about 60–80 ml of fluid. In it, the bottom, body and neck are isolated, which continues into the cystic duct. The saccular dilatation of the gallbladder neck is called Hartmann's pouch. The gallbladder has three layers: serous, muscular and mucous. The serous membrane at the usual location of the gallbladder covers only its free surface, the part facing the liver is covered with loose connective tissue, it contains the so-called Luschke passages. Luschke's passages start from the small intrahepatic bile ducts and reach the gallbladder mucosa (the latter circumstance must be taken into account when performing cholecystectomy). In the wall of the gallbladder there are also branched intussusceptions of the mucous membrane, penetrating through the entire muscle layer and in contact with the serosa (Rokitansky-Ashoff sinuses). They play an important role in the development of biliary peritonitis without gallbladder perforation.

The gallbladder is supplied with blood from the cystic artery, which in most cases arises from the right hepatic artery. Smaller blood vessels enter from the liver through the gallbladder bed. Blood from the gallbladder drains through the cystic veins into the portal vein system. In the gallbladder mucosa and under the peritoneum are lymphatic vessels that pass through the lymph node at the neck of the gallbladder (Moscagni's node) to the nodes along the common bile duct and then into the thoracic lymphatic duct. The innervation of the gallbladder and biliary tract is carried out due to the hepatic and cystic nerve plexuses (celiac nerve plexus), as well as due to the left vagus nerve and the right phrenic mixed nerve, which causes irradiation of pain during inflammation in this area to the right shoulder girdle and the right half neck.

When eating, the gallbladder contracts 1-2 times, while bile enters the intestine, where it participates in the digestive process. The most significant effect is produced by the gastrointestinal hormone cholecystokinin-pancreozymin (CCK-PZ), which is formed in the chromaffin cells of the duodenum and, to a lesser extent, also in the ileum and jejunum. CCK-PZ is produced when food enters the duodenum and gives a signal to the liver and gallbladder about the need for its further digestion - stimulating the contraction of the gallbladder, increasing the secretion of bile by the liver, and relaxing the sphincter of Oddi. In addition, CCK-PZ stimulates the secretory function of the pancreas. Nerve stimuli have less effect on gallbladder motility.

Gallstone disease (GSD)- metabolic disease of the hepatobiliary system, characterized by the formation of stones in the hepatic bile ducts (intrahepatic cholelithiasis), in the common bile duct (choledocholithiasis) or in the gallbladder (cholecystolithiasis) (P.Ya. Grigoriev, 1993).

International Classification of Diseases - 10

Diseases of the gallbladder, biliary tract and pancreas (K80 - K87)

K80 Cholelithiasis [cholelithiasis].

K80.0 Gallbladder stones with acute cholecystitis.

K80.1 Gallbladder stones with other cholecystitis.

K80.2 Gallbladder stones without cholecystitis.

K80.3 Bile duct stones with cholangitis.

K80.4 Stones of the bile duct with cholecystitis.

K80.5 Bile duct stones without cholangitis or cholecystitis.

Etiology, epidemiology and pathogenesis of gallstone disease

In developed countries, gallstone disease is one of the most common diseases. According to various authors, in Germany gallstones occur in 10-15% of the population, in Russia every 19 people aged 41 to 50 years old are sick, and every seventh person over the age of 71 years old. In women, cholelithiasis occurs 3-5 times more often than in men.

There are several types of stones depending on the chemical composition:

cholesterol;

pigmented (contain mainly bilirubin and its polymers);

lime (calcium);

mixed.

Theories of the pathogenesis of cholelithiasis

The most substantiated theories of the formation of gallstones:
1) infectious; 2) stagnation of bile; 3) disorders of lipid metabolism.

Each of these theories reflects a certain part of the process of lithogenesis.

The formation of cholesterol stones occurs only in the presence of bile supersaturated with cholesterol, while a decrease in the motor activity of the gallbladder, an increase in mucus secretion, and the presence of infection are also important. Factors affecting the formation of cholesterol stones:

gender - women get sick 3-5 times more often than men, which is probably due to hormonal differences (estrogens stimulate liver receptors for lipoprotein, promote the absorption of cholesterol and its secretion into bile);

genetic and ethnic factors;

age - over the years, the risk of stones is higher;

nutrition - high-calorie food containing a significant amount of cholesterol, easily digestible carbohydrates, animal fats;

pregnancy - a decrease in the contractile activity of the gallbladder and hormonal changes;

diseases of the terminal ileum, taking certain medications.

The causes of pigment stones are less understood. It is believed that they are formed due to:

liver damage, leading to the appearance of pigments of a pathological structure, which easily combine with calcium ions and precipitate;

increased formation of unbound bilirubin (hemolytic diseases, liver diseases);

the transformation of normal pigments into insoluble compounds under the influence of pathological processes in the biliary tract (infection, surgical procedures).

Pigment stones often form in the common bile duct.

It is customary to distinguish three stages of cholelithiasis: physicochemical (there are signs of an increase in the lithogenicity of bile, there is no clinical, radiological and sonographic picture of the disease), latent (there are stones in the gallbladder that do not manifest themselves clinically, but are detected radiographically and during ultrasound examination) , clinical (calculous cholecystitis).

The clinical manifestations of gallstone disease are very diverse, which was the reason for the selection of the following forms of the disease:

latent (patients do not complain);

dyspeptic chronic (the main complaints are a feeling of heaviness in the pit of the stomach, a feeling of pressure in the epigastric region, heartburn, flatulence);

chronic pain (occurs without pronounced pain attacks, moderate pains of a aching nature in the epigastrium and right hypochondrium, aggravated by eating);

biliary colic and chronically recurrent form (manifested by sudden and recurring pain attacks);

angina pectoris form (in elderly people suffering from ischemic heart disease - it resembles an angina attack, after cholecystectomy the attacks disappear).

Chronic calculous cholecystitis

Depending on the severity of pain, dyspeptic, inflammatory syndromes, there are:

chronic calculous cholecystitis in remission;

chronic calculous cholecystitis in the acute stage.

There are primary chronic calculous cholecystitis, residual chronic calculous cholecystitis (an attack of acute cholecystitis in history), chronic recurrent cholecystitis (repeated pain attacks).

Chronic calculous cholecystitis is manifested primarily by pain syndrome - dull pain in the right hypochondrium and attacks of biliary colic. Other symptoms (a feeling of heaviness in the right hypochondrium, heartburn, nausea, vomiting, constipation, intolerance to fatty foods) are nonspecific and may be due to other diseases.

Gallbladder colic is a symptom complex that occurs as a result of the movement of the calculus to the region of the neck of the gallbladder. As a result, irritation of the gallbladder mucosa and an increase in intravesical pressure occur.

Clinically, biliary colic is manifested by an attack of intense pain in the right hypochondrium and epigastrium, radiating to the shoulder, neck, and right shoulder blade. Less commonly, pain radiates to the left, to the region of the heart, simulating an attack of angina pectoris. Simultaneously with the pain, nausea and vomiting appear, which does not bring noticeable relief. An attack of biliary colic can be triggered by the intake of fatty foods, spices, physical stress, and sometimes emotional factors.

One can talk about biliary colic only in the case when the pain syndrome is quickly (within 6 hours from the onset of the attack) stopped by the use of antispasmodics and analgesics, and the inflammatory syndrome in the patient is absent or mild. If there is an inflammatory syndrome, and the pain syndrome is not relieved by the administration of antispasmodic analgesics within 6 hours, it should be assumed that the patient has acute cholecystitis or an exacerbation of chronic cholecystitis.

Inspection. When examining a patient, it is possible to identify signs that make it possible to suspect cholelithiasis (gender, age, obesity, metabolic disorders, signs of chronic liver disease).

Palpation. Examination of the abdomen is performed in the supine position, legs slightly bent at the knees, hands at the seams. During an attack of biliary colic, flatulence, restriction of respiratory movements is possible. Of particular importance is the identification of pain in the study of certain points. A number of symptoms characteristic of various forms of cholelithiasis are described.

Kera's symptom - pain when inhaling during palpation of the right hypochondrium.

Symptom Ortner-Grekov - tapping the edge of the palm on the right costal arch causes pain.

Boas' symptom - detection of a site of hyperesthesia in the lumbar region.

Murphy's symptom - evenly pressing the thumb on the area of ​​the gallbladder, the patient is asked to take a deep breath; at the same time, he “takes” his breath and there is pain in this area.

Symptom Mussi-Georgievsky - pain on palpation between the legs of the sternocleidomastoid muscle.

Laboratory research

In the case of chronic calculous cholecystitis without exacerbation and biliary colic, there may be no changes in the general and biochemical blood tests.

If an inflammatory syndrome is detected (leukocytosis, an increase in the number of stab neutrophils, an increase in ESR), acute cholecystitis should be suspected.

An increase in the concentration of AST, ALT, alkaline phosphatase and bilirubin indicates that the patient has complications of cholelithiasis (acute cholecystitis, choledocholithiasis, cholangitis, etc.).

And instrumental diagnostic methods

Ultrasound examination abdominal cavity is the method of choice in the diagnosis of gallstone disease.

The sensitivity of the method for chronic uncomplicated calculous cholecystitis is 95%, the specificity is 90–95%. The study is accessible and safe for the patient. Signs of cholelithiasis - detection of calculi in the gallbladder, manifested by intense echoes with a distinct acoustic shadow that propagates and overlaps the image of the structures lying behind them. Acute cholecystitis is characterized by the presence of stones (in the neck, not displaced) in combination with signs of inflammation of the gallbladder (increase in size, thickening of the wall, the appearance of "layering" of the wall), a change in the wall of the gallbladder (thickening). The method allows, although with less sensitivity and specificity, to assess the state of the bile ducts (size, condition of the walls, the presence of cholangioliatase).

X-ray studies of the gallbladder
and bile ducts

Unlike kidney stones, only 10% of gallstones are visualized on plain radiography. The possibility of their detection is due to the content of calcium in them.

X-ray contrast study (oral and intravenous cholecystocholangiography) is based on the ability of the liver to excrete iodine-containing substances with bile. The study is informative only in the case of preserved liver function and the absence of bilirubinemia, has a low degree of reliability of the results, and may be accompanied by complications. All this largely limits the application of the above methods.

Biliary scintigraphy

The technique is based on the capture of labeled 99m Tc by liver cells and the release of the latter with bile. The resolution of biliary scintigraphy in jaundice is significantly inferior to other imaging methods.

Computed tomography (CT)

Standard CT has a low accuracy in diagnosing gallbladder stones, but it can be used to distinguish cholesterol stones from stones containing calcium, which is important for deciding whether a patient should undergo shock wave lithotripsy or litholytic therapy. CT is used mainly to assess the condition of the tissues around the gallbladder and ducts, to determine the dilation of the bile ducts and the level of their obstruction, and pancreatic damage. Spiral CT allows you to conduct a study quickly (15–30 s), assess the state of the vessels of the liver and ducts, and obtain a three-dimensional image.

Magnetic resonance imaging (MRI)

FROM The method is based on recording the energy released from protons ordered in a magnetic field upon transition to a lower energy level.

With insufficient information content of ultrasound and CT, the use of magnetic resonance cholangiopancreatography (MRCP) makes it easier to identify the expansion of the bile ducts, volumetric formations and stones. The study is highly informative for diagnosing obstruction of the bile ducts and establishing its cause.

Laparoscopy

Visual examination of the abdominal organs using optical instruments is a fairly effective diagnostic method for damage to the liver, gallbladder and bile ducts. With cholelithiasis, the need for laparoscopy occurs most often in the differential diagnosis of jaundice, suspicion of a tumor of the bile ducts or gallbladder. Despite the high diagnostic value of laparoscopy, the indications for it must be strictly justified, since the latter is an invasive procedure and may be accompanied by the development of severe complications.

Endoscopic retrograde cholangiopancreatography (ERCP)

FROM With the help of an endoscope, a large duodenal papilla is found, which cannulate. Retrograde, under the control of the endoscope and in the conditions of the X-ray room, an X-ray is introduced contrast agent. The study allows you to assess the state of the entire biliary system, in some cases, and the pancreatic duct.

The main indication is to determine the causes of obstructive jaundice and pain syndrome when other research methods are not informative: clinical, laboratory, sonographic, etc.

ERCP may be accompanied by the development of complications typical of diagnostic gastroduodenoscopy - reaction to drugs, aspiration, cardiopulmonary complications, perforation of a hollow organ, as well as specific complications - pancreatitis, cholangitis, bleeding.

Percutaneous transhepatic cholangiocardia (PTCH)

First performed in 1937 (P.Huard) by puncture of dilated bile ducts and injection of lipiodol. Prior to the advent of ultrathin needles of the Chiba type, the procedure was accompanied by a significant number of complications (bleeding and bile flow into the abdominal cavity).

Currently, PTCG, along with ERCP, is the method of choice in the diagnosis of obstructive jaundice, and in patients after resection of the stomach according to Billroth II, it is the only possible one.

The intervention is carried out in an operating room equipped with an x-ray unit. The puncture is carried out in the VIII or IX intercostal space on the right along the mid-axillary line after anesthesia of the skin, subcutaneous tissue, intercostal muscles. After the needle is inserted, the mandrin is removed and a contrast agent is injected. It is possible to perform a puncture under ultrasound guidance.

Examination of a patient with chronic calculous cholecystitis should include mandatory ultrasound examination of the gallbladder, bile ducts, liver and pancreas; fibrogastro-duodenoscopy (if it is impossible to perform - x-ray of the stomach and duodenum); ECG; general blood and urine analysis, biochemical blood test (total protein, bilirubin, urea, creatinine, electrolytes, AST, ALT, alkaline phosphatase, amylase, viral hepatitis markers), coagulogram, blood grouping and Rh factor. If you suspect the presence of damage to the bile ducts and pancreas, additional methods described above for their study are necessary.

Patients with comorbidities should be examined to correct treatment or determine contraindications to surgery.

Differential Diagnosis

Principles of treatment of gallstone disease

Treatment of gallbladder stones

The presence of gallstones in the gallbladder requires immediate treatment. This is due to the presence of clinical manifestations of the disease (pain, dyspeptic disorders, etc.) and the risk of complications.

In the case of stone carriers (accidentally detected calculi, absence of a clinic), two approaches are possible: 1) surgical treatment with minimally invasive methods to prevent possible complications;
2) observation. More justified is the active treatment of stone carriers in the absence of contraindications to surgical treatment.

Currently, the main method of treatment of this pathology is surgical. Non-surgical treatments for cholelithiasis have limited indications, a high recurrence rate, and should only be used in a limited number of patients.

Tactics for chronic calculous cholecystitis without exacerbation - planned surgery. The emergence of minimally invasive cholecystectomy techniques and advances in anesthesiology and intensive care have significantly reduced the number of contraindications to surgery.

Patients with a clinical picture of biliary colic or chronic calculous cholecystitis should be hospitalized in the surgical department, where they undergo conservative therapy aimed at stopping the attack. Treatment includes: 1) providing rest and creating functional rest for the body (bed rest, hunger);
2) relief of pain syndrome (novocaine blockade - pararenal, round ligament of the liver, the introduction of non-narcotic analgesics, antispasmodics); 3) infusion therapy. There is evidence of the effectiveness of non-steroidal anti-inflammatory drugs (diclofenac, indomethacin) and antiplatelet agents (pentoxifylline). Antibacterial therapy is prescribed in patients with comorbidities and a high risk of developing acute cholecystitis (2-3 generation cephalosporins or alternative regimens - fluoroquinolone, clindamycin, amoxiclav, etc.). Simultaneously with treatment, patients undergo an emergency examination, including an assessment of the state of the cardiovascular and pulmonary systems, liver and kidney function, and correction of the treatment of comorbidities. When arresting an attack, surgical treatment is performed without discharge of the patient from the hospital. If it is necessary to conduct additional therapy for concomitant pathology, the operation is performed after treatment in a therapeutic hospital.

Surgical treatments for chronic
calculous cholecystitis

Traditional (open) cholecystectomy.

Mini-access cholecystectomy (laparoscopically assisted cholecystectomy).

Videolaparoscopic cholecystectomy.

Traditional laparotomic cholecystectomy.

X olecystectomy involves the removal of the gallbladder along with stones after separate ligation or clipping of the cystic artery and duct. First performed by the German surgeon Langebuch in 1882, in Russia for the first time by Yu.F. Kosinsky - 1889.

For cholecystectomy, upper median laparotomy and oblique subcostal Kocher and Fedorov approaches are currently used.

There are two options for performing cholecystectomy: "from the bottom" and "from the neck" (antegrade and retrograde cholecystectomy).

Cholecystectomy "from the bottom" is performed in case of infiltrative-inflammatory changes in the cervical region, when there are difficulties in identifying and isolating the cystic artery and duct. With this variant of cholecystectomy, there is more pronounced bleeding from the tissues of the gallbladder and there is a risk of movement of small stones from the gallbladder. In this case, however, there is less chance of damage to the bile ducts.

AT While performing traditional cholecystectomy, there is the possibility of intraoperative diagnosis of biliary tract pathology: examination, palpation of extrahepatic bile ducts, cholangiomanometry and cholangio-debitometry, intraoperative cholangiography, choledochoscopy, intraoperative ultrasound, diagnostic choledochotomy. The completion of the operation depends on the identified changes (external drainage, biliodigestive anastomosis, transduodenal papillosphincterotomy).

The disadvantages of the operation are a significant surgical trauma, a long period of temporary disability, a cosmetic defect, the possibility of developing early (suppuration of the wound, eventration, etc.) and late (ventral hernia) postoperative complications.

Laparoscopic cholecystectomy

The first non-abdominal cholecystectomy was performed by the French surgeon Philippe Mouret in 1987 in Lyon.

Under general anesthesia, a Veress needle is inserted into the abdominal cavity and carbon dioxide is injected (creating a carboxyperitoneum). The laparoscope and instruments are then inserted at typical points. The cystic duct and vessels of the gallbladder are isolated and clipped. The gallbladder is isolated from the bed using electrocoagulation and removed.

During laparoscopic cholecystectomy, instrumental palpation of the common bile duct is possible, if necessary, intraoperative cholegraphy and choledoscopy. The possibility of performing laparoscopic choledocholithotomy and choledochoduodenoanastomosis was shown.

Laparoscopic cholecystectomy is the gold standard for the treatment of chronic calculous cholecystitis.

However, there are a number of contraindications to this surgical intervention:

severe cardiopulmonary disorders;

uncorrectable disorders of hemostasis;

peritonitis;

late pregnancy;

obesity II-III degree;

pronounced cicatricial-inflammatory changes in the neck of the gallbladder and hepatoduodenal ligament;

acute pancreatitis;

mechanical jaundice;

biliodigestive and biliary fistulas;

gallbladder cancer;

previous operations on the upper floor of the abdominal cavity.

These contraindications are not absolute. The introduction of new treatment technologies, such as the gasless lifting method, the expansion of the possibilities of video-laparoscopic intraoperative examination of the biliary tract (cholegraphy, choledochoscopy, intraoperative ultrasound) and treatment significantly reduce this list.

Undoubted advantages of laparoscopic cholecystectomy: low trauma, good cosmetic effect, significant reduction in mortality and postoperative complications, rapid rehabilitation and reduction of temporary disability.

Cholecystectomy from a mini-access

Cholecystectomy with this technique is performed from a small incision of the abdominal wall - 3–5 cm. Adequate access for operating is created by a special set of mini-assistant instruments (annular retractor, a set of mirror hooks and a lighting system). An additional set of instruments allows for a number of diagnostic and therapeutic manipulations on the common bile duct (cholangiography, choledochotomy, choledoduodenostomy, drainage of the common bile duct).

Mini-access cholecystectomy, according to some authors, is comparable to LCE in terms of trauma and quality of life of operated patients.

Non-surgical treatments for gallstones

Oral litholytic therapy.

Contact litholytic therapy.

Extracorporeal shock wave lithotripsy followed by oral litholytic therapy.

Oral litholytic therapy

The method is based on the introduction of exogenous bile acids into the patient's body. The main drugs are ursodeoxycholic and chenodeoxycholic acids. Ursodeoxycholic acid prevents the absorption of cholesterol in the intestine and promotes the transition of cholesterol from stones into bile. Chenodeoxycholic acid inhibits the synthesis of cholesterol in the liver and also promotes the dissolution of cholesterol stones. The most effective treatment is a combination of these drugs.

The technique has a number of limitations and disadvantages:

only cholesterol stones of a limited size are dissolved in 60-80% of cases (the need for CT is the optimal attenuation coefficient of less than 70 Hounsfield units, stone diameter is less than 1.5 cm);

long-term treatment (more than 2 years);

recurrence rate - 50%;

the functional activity of the gallbladder should be preserved (the need for additional studies);

the cost of treatment is much higher than that of surgical treatment.

Extracorporeal shock wave lithotripsy

The method is based on generating a high-energy shock wave (often piezoelectric) and directing it to the calculus under ultrasound control. The method can be used in patients with a functioning gallbladder, a single calculus up to 2 cm in diameter. The axis of the shock wave should not pass through the lung. The formed fragments of the calculus ideally pass through the cystic and common bile ducts into the duodenum. Lithotripsy is currently usually supplemented by oral administration of litholytic drugs. The disadvantages of the method are frequent complications from the bile ducts and pancreas, a rather high recurrence rate, the need to take medications for a long time (see above).

Contact dissolution of gallstones

The essence of the method is to bring a liquid dissolving drug directly into the gallbladder and ducts. In the presence of calculi in the gallbladder, the patient undergoes percutaneous transhepatic puncture of the gallbladder under X-ray or ultrasound control. A catheter is placed through the needle and guidewire into the gallbladder. Methylterzbutyl ether is injected through the catheter and the substance is immediately aspirated back. The duration of treatment is from 4 to 12 hours.

Since the gallbladder is not removed, then, as with the above methods, the recurrence rate reaches 50-60%. Possible complications associated with the development of chemical inflammation of the gallbladder and absorption of the drug in the gastrointestinal tract.

Acute calculous cholecystitis

Acute calculous cholecystitis - acute inflammation of the gallbladder, one of the most common complications of cholelithiasis, develops in approximately 20-25% of patients with chronic calculous cholecystitis.

According to the absolute number of deaths, acute cholecystitis surpasses acute appendicitis, strangulated hernias, perforated gastroduodenal ulcers, only slightly yielding to acute intestinal obstruction. The overall postoperative mortality ranges from 2-12%, does not tend to decrease and reaches 20% in the elderly.

Acute acalculous cholecystitis occurs in the practice of emergency surgery in no more than 2-5% of cases - mainly, these are vascular lesions of the gallbladder in people with widespread atherosclerosis, diabetes mellitus, as well as acute inflammation against the background of a septic condition, severe trauma, etc. . P.

Pathogenesis

In the pathogenesis of acute calculous cholecystitis, certain successively developing changes can be traced: an increase in intravesical pressure, microcirculatory disorders, progressive hypoxia of the gallbladder wall, infection, the appearance of morphological signs of an inflammatory process in the bladder wall with different severity of destructive changes.

It is generally accepted that the development of acute calculous cholecystitis is associated with occlusion of the cystic duct, which occurs either due to obstruction by a small calculus from the inside, or due to external compression by a calculus wedged into Hartmann's pouch, swelling of the gallbladder neck. Obstruction of the cystic duct and inflammation of the bladder wall alters the absorptive capacity of the gallbladder mucosa, leading to biliary hypertension. Biliary hypertension leads to arteriovenous shunting of blood in the bladder wall and the development of hypoxic changes. Violations of microcirculation, in turn, contribute to a decrease in tissue resistance and infection.

Classification

There is no single classification that includes pathomorphological and clinical variants of acute cholecystitis.

There are primary acute cholecystitis (first detected), when it is the first clinical manifestation of cholelithiasis, and recurrent.

Morphological classification of acute cholecystitis.

Catarrhal - the inflammatory process is limited to the mucous and submucosal layers, there is edema, slight infiltration of the wall with neutrophils.

Phlegmonous - all layers of the wall are edematous, diffusely infiltrated with neutrophils, there are mucosal defects, the vessels of the gallbladder wall are plethoric, thrombosed.

Gangrenous- extensive areas of necrosis of all layers of the gallbladder wall.

Perforated.

Clinically, acute calculous cholecystitis is divided into complicated and uncomplicated. Complications of acute calculous cholecystitis are divided depending on:

the nature of the lesion of the bile ducts (choledocholithiasis, stenosis of the papilla of Vater, cholangitis, strictures of the bile ducts);

localization of the pathological process - empyema of the gallbladder, acute obstructive cholecystitis, perivesical infiltrate, perivesical abscess, liver abscess, dropsy of the gallbladder;

lesions of other organs and systems - acute pancreatitis, peritonitis, liver abscesses, biliary cirrhosis.

Clinic

People of any constitution, sex and age get sick, but the main group is women aged 45 years and older. Most patients have a history of chronic calculous cholecystitis.

Major Syndromes in acute calculous cholecystitis:

pain (a characteristic attack with typical irradiation);

inflammatory (symptoms of intoxication and infection);

dyspeptic;

peritoneal.

Clinical symptoms- enlarged and painful on palpation of the gallbladder, muscle tension in the right hypochondrium, symptoms of Murphy, Ortner-Grekov, Kera, Mussi-Georgievsky.

The disease begins acutely with pain in the right hypochondrium and epigastrium, pain usually occurs late at night or in the morning, radiates to the back below the angle of the right shoulder blade, to the right shoulder, or, less commonly, to the left half of the trunk, and may resemble an angina attack. An attack can be triggered by a late plentiful dinner, fatty foods. Characterized by increased sweating, pain and a motionless posture on the side with the legs pressed to the stomach. Often, patients apply a heating pad to the right hypochondrium. Typical signs are nausea, vomiting, fever up to 38°C, abdominal distention. The clinical course of acute cholecystitis to a certain extent corresponds to the nature of morphological changes in the gallbladder. Yes, at catarrhal form inflammation, the general condition of the patient does not suffer: body temperature is normal, intoxication is not expressed, moderate pain in the right hypochondrium, nausea, and flatulence are noted. Vomiting is not typical. On palpation of the abdomen, moderate pain in the right hypochondrium is determined without symptoms of peritoneal irritation. The gallbladder is rarely palpated - 10-15% of cases. Phlegmonous form The disease is characterized by a vivid clinical picture in the form of an intense pain syndrome with characteristic irradiation. The patient has severe weakness, fever, dry mouth, tachycardia up to 100 beats per minute. Dyspeptic syndrome is characterized by nausea, repeated vomiting, and bloating. Pain is noted on palpation of the abdomen in the right hypochondrium and epigastrium, an enlarged painful gallbladder is palpated.

The most pronounced clinical manifestations gangrenous and gangrenous-perforative form of acute cholecystitis. Signs of general intoxication take the first place: patients are adynamic, dehydrated, tachycardia more than 100 beats per minute, fever. An objective examination of the abdomen is painful in all departments, there are symptoms of irritation of the peritoneum.

While maintaining the obstruction of the cystic duct and the sterility of bile in the bladder, the latter can be absorbed, and the cavity of the gallbladder remains filled with a clear liquid - dropsy of the gallbladder. When the contents of the cavity are infected, empyema of the gallbladder develops, the course of which can be acute or chronic.

X A typical symptom of dropsy of the gallbladder is the presence of a mobile, elastic, painless gallbladder in the absence of jaundice, signs of inflammation and intoxication. With empyema of the gallbladder after conservative therapy, the patient's condition returns to normal, however, pain persists on palpation in the gallbladder area, subfebrile temperature remains, and a moderate inflammatory syndrome.

Features of the flow acute calculous cholecystitis in elderly and senile patients - a rapid progression of destructive changes in the gallbladder with involvement of the extrahepatic biliary tract in the process, a discrepancy between the clinical picture and morphological changes. The clinic is not always pronounced: the temperature may be low, pain and symptoms of the disease are either mild or absent, symptoms of intoxication prevail. These patients, as a rule, have concomitant pathology from other organs and systems, and the syndrome of "mutual aggravation" is often formed. Among the atypical forms of acute cholecystitis, the so-called cardiac form is described, in which the pain syndrome manifests itself in the form of pain in the heart or behind the sternum (cholecystocoronary syndrome - S.P. Botkin). Most often, such pains are observed in persons of older age groups.

Diagnostics

Laboratory diagnostics

Complete blood count - leukocytosis is characteristic with an increase in the number of stab neutrophils, an increase in ESR.

Biochemical analysis of blood - it is possible to increase the content of AST, ALT, alkaline phosphatase, bilirubin.

Mandatory laboratory tests in patients with acute calculous cholecystitis: complete blood count, blood glucose, bilirubin, ALT, ACT, amylase, creatinine, urea, coagulogram, blood test for RW, blood type and Rh factor, general analysis and urine diastasis, viral hepatitis markers.

instrumentaldiagnostics

O The main diagnostic method is ultrasonography.

Signs of acute calculous cholecystitis:

an increase in the size of the gallbladder (more than 10 cm in length and 4 cm in width);

wall thickening (over 3 mm);

doubling (layering) and fuzzy-bone walls;

the presence in the lumen of a hyperechoic suspension and stones fixed in the neck;

signs of acute perivesical changes;

positive ultrasonic sign of Murphy.

Valuable is the possibility of dynamic ultrasonography to evaluate the effectiveness of conservative therapy.

Plain radiography of the abdominal organs in 10% of cases it can reveal calculi in the gallbladder, its use is justified in case of an unclear clinical picture for the purpose of differential diagnosis (acute intestinal obstruction, perforation of a hollow organ).

Application of laparoscopy in complex cases, it allows to clarify the data of ultrasonography, especially in the case of cholecystopancreatitis. Important is the possibility of carrying out not only diagnostic, but also therapeutic measures (decompression of the gallbladder, sanitation of the abdominal cavity).

Biliary scintigraphy. If acute cholecystitis is suspected, scintigraphy can assess the patency of the cystic duct. The absence of an image of the gallbladder with a passable common bile duct and the appearance of a radioisotope in the intestine with a high probability indicates acute cholecystitis.

Examination of a patient with acute calculous cholecystitis involves performing without fail Ultrasound of the abdominal organs, FGDS, chest x-ray, ECG (according to indications - x-ray of the abdominal organs, CT).

Differential diagnosis is carried out with: 1) acute appendicitis; 2) acute pancreatitis; 3) perforated ulcer; 4) myocardial infarction;
5) right-sided pleuropneumonia; 6) right-sided renal colic;
7) aneurysm of the abdominal aorta.

Treatment

Prehospital stage

The diagnosis or reasonable assumption of the presence of acute cholecystitis, especially in the case of established cholelithiasis, is an indication for referring the patient to a surgical hospital. With an unresolved diagnosis of acute cholecystitis, the use of local heat (heaters) on the abdomen, as well as the use of enemas and laxatives, is contraindicated. If the patient refuses hospitalization, he and his relatives must be warned in writing about the possible consequences with a corresponding entry in the medical record. In case of unauthorized departure of the patient before the diagnosis is determined from the admission department of the surgical hospital, the doctor of the admission department is obliged to inform the clinic at the patient's place of residence for an active examination by the surgeon of the clinic at home.

Hospital treatment

Along the course, acute calculous cholecystitis is divided into three groups: common (urgent), progressive, regressing (Grishin I.N., Zavada N.V.)

Widespread acute calculous cholecystitis corresponds to gangrene and (or) perforation of the gallbladder with local peritonitis. In this case, emergency surgery is indicated (traditional cholecystectomy, sanitation and drainage of the abdominal cavity, according to indications - external drainage of the biliary tract).

The rest of the patients undergo intensive conservative treatment during the first day, aimed at stopping the inflammatory process and restoring the natural outflow of contents from the gallbladder. Against the background of this treatment, an emergency ultrasound examination is performed, which provides objective information about the size of the gallbladder, the condition of its walls, the presence and location of stones and perivesical complications.

conservative therapy. Standard conservative treatment of acute calculous cholecystitis includes dehydration infusion therapy with crystalloid and colloid solutions, analgesics (analgin, tramadol, ketanov, etc.), antispasmodics (no-shpa, papaverine, baralgin), anticholinergics (atropine), novocaine blockade of the round ligament liver, subxiphoidal or pararenal novocaine blockade, correction of concomitant pathology. For prolonged administration of novocaine and antibacterial drugs, catheterization of the round ligament of the liver is used.

Taking into account rheological disturbances, an increase in the surface tension of blood plasma and erythrocyte membranes, as well as an increase in coagulation activity in acute calculous cholecystitis, the use of drugs that improve microcirculation (pentoxifylline, reopoliglyukin, etc.) is recommended. There are reports of the effective use of non-steroidal anti-inflammatory drugs (indomethacin, diclofenac) for the treatment of acute calculous cholecystitis.

The use of antibacterial drugs is justified in case of suspicion of the presence of destructive (phlegmanous or gangrenous) cholecystitis, cholangitis, extravesical complications, as well as in patients with a high operational risk for the prevention of pyoinflammatory complications. A feature of conservative therapy for acute calculous cholecystitis is that the latter is often a preoperative preparation.

Progressive acute calculous cholecystitis is defined in the absence of the effect of conservative therapy within 48-72 hours from the start of treatment or in the presence of clinical and ultrasound signs of destructive cholecystitis and the progression of local and general symptoms of inflammation. Such patients are shown urgent surgical treatment (48-72 hours from the moment of admission to the hospital).

With regressing acute calculous cholecystitis against the background of conservative treatment, clinical symptoms are resolved, and laboratory parameters return to normal. In this case, patients continue to undergo conservative treatment and a comprehensive examination, while specifying the indications for delayed or planned surgical treatment.

O selection operation in the absolute majority of cases - traditional or laparoscopic cholecystectomy with intraoperative revision of the biliary tract.

The problem of choosing treatment tactics in senile patients with a high operational and anesthetic risk is difficult. Features of the course of acute calculous cholecystitis in elderly and senile patients are the rapid progression of destructive changes in the gallbladder with involvement of the extrahepatic biliary tract in the process, the discrepancy between the clinical picture and morphological changes. These patients, as a rule, have concomitant pathology from other organs and systems, often a syndrome of "mutual aggravation" is formed.

In such patients, two-stage treatment is possible. At the first stage, if conservative therapy fails and there is a high risk of radical treatment, the patient undergoes cholecystostomy, then, after the condition is compensated, cholecystectomy is performed.

Complications of calculous cholecystitis

Choledocholithiasis- the presence of stones in the extrahepatic bile ducts. Occurs according to different authors in 20-30% of patients with cholelithiasis. Bile duct stones in 70–90% of cases are cholesterol stones that have migrated from the gallbladder.

Clinical manifestations of choledocholithiasis occur in two thirds of patients.

H the most characteristic: pain syndrome (localization and nature of pain does not differ from those in biliary colic), dyspeptic syndrome (nausea, vomiting, bloating, etc.), inflammatory syndrome, cholestasis syndrome and obstructive jaundice. The occurrence of inflammation of the ducts against the background of impaired bile flow is characterized by the classic Charcot triad (jaundice, fever, chills).

Laboratory indicators with “silent” bile duct stones, they either do not differ from the norm, or change slightly. Possible leukocytosis, increased levels of bilirubin and transaminases, increased activity of cholestasis enzymes - alkaline phosphatase and γ-glutamyl transferase. With complete or partial obturation with the development of ascending cholangitis, a pronounced increase in all of the listed indicators is observed.

Instrumental diagnostics

Standard ultrasound examination reveals choledocholithiasis in 40–70% of cases. This is due to the small size of the calculus, the absence of an ultrasound shadow, air overlay, and the absence of dense echo structures. An indirect sign of blockage of the bile ducts is their expansion, which is detected during the study. A promising direction in the diagnosis of choledocholithiasis is the use of endoscopic ultrasound.

The main highly informative preoperative methods for diagnosing choledocholithiasis: ERCP, PTCG, magnetic resonance cholangiopancreatography, CT.

Bile duct stones, even in the case of an asymptomatic course, can cause numerous complications, which necessitates treatment.

Complications of bile duct stones

Obstruction of the bile duct, obstructive jaundice.

cholestasis, cholangitis.

Liver abscess, sepsis.

Secondary biliary cirrhosis.

Biliary fistulas.

Acute pancreatitis.

Intestinal obstruction.

Cholangiocarcinoma.

Treatment

AT
The choice of a treatment option for chronic calculous cholecystitis in combination with choledocholithiasis will depend on the severity of clinical manifestations, the time of diagnosis (before surgery, during surgery), and the presence of other complications (stenosis of the MSD, cholangitis, obstructive jaundice).

Two-stage treatment

Sanitation of the biliary tract - ERCP, papillosphincterotomy, extraction of calculi (Dormia's basket).

Cholecystectomy is preferably laparoscopic.

One-time treatment

During open or laparoscopic cholecystectomy, choledochotomy and choledocholithotomy are performed.

Completion of choledocholithotomy.

Blind suture of the common bile duct - confidence in the sanitation of the biliary tract and the absence of stenosis of the BSDK.

Blind suture of the common bile duct + external drainage of the biliary tract according to Halsted-Pikovsky (through the stump of the cystic duct).

Choledochoduodenoanastomosis - with multiple calculi, a wide atonic duct, a history of pancreatitis, stenosis of the BSDK.

External drainage on a T-shaped drainage (according to Ker) - changes in the duct wall, multiple calculi.

If residual or recurrent choledocholithiasis is detected in the postoperative period, EPST and sanitation of hepaticocholedochus are indicated. If it is impossible - a standard laparotomy, choledocholithotomy, choledochoduodenostomy or external drainage of the choledochus according to Pikovsky.

Stenosis of the major duodenal papilla

FROM Vater's juice tenoses, for the most part, are secondary and occur against the background of cholelithiasis due to the passage or wedging of calculi. Less commonly, the causes of stenosis of the terminal part of the common bile duct are inflammatory changes in the head of the pancreas or duodenum.

Clinical manifestations of stenosis are varied and sometimes non-specific. Typical attacks of biliary colic or pain in the right hypochondrium and epigastrium, dyspeptic syndrome. In case of violation of the bile outflow, there are signs of cholestasis, cholangitis and obstructive jaundice.

Laboratory studies: leukocytosis, increased levels of bilirubin and trans-aminases, cholestasis syndrome (alkaline phosphatase and γ-glutamyl transferase), an increase in amylase and lipase activity is possible.

Instrumental diagnostics: ERCP, endoscopic ultrasound, MRI (dilation of the common bile duct, slowing down the outflow of contrast, slow contractions of the duodenal papilla). Endoscopic manometry allows the most complete assessment of the condition of the BDMS, however, the method is rather complicated and is not widely used.

Treatment

In the presence of jaundice and cholangitis - two-stage: 1) EPST, rehabilitation of hepaticocholedochus; 2) planned cholecystectomy. It is possible to perform a traditional cholecystectomy, choledocholithotomy, imposition of a biliodigestive anastomosis.

Cholangitis - inflammation of the bile ducts

The disease was first described by J.M. Charkot (1877) in the form of a triad of signs: fever with chills, jaundice and pain in the upper abdomen. B.M. Reynolds (1959) added to Charcot's triad signs of toxic shock in the form of clouding of consciousness and arterial hypotension arising from the accumulation of purulent bile in the ducts due to obstruction of the terminal part of the common bile duct.

The most common cause of cholangitis is choledocholithiasis, less often it occurs against the background of biliary stenosis or strictures. Currently, there is an increase in the frequency of tumor obstruction as a cause of cholangitis.

The pathophysiology of cholangitis has three components: cholestasis, increased ductal pressure, and bacterial infection.

Normally, small amounts of intestinal microorganisms are constantly present in bile (duodenobiliary reflux). With obstruction of the bile ducts, they multiply, and with complete obstruction, the concentration of microorganisms in bile approaches their concentration in feces. The microflora of bile in cholangitis corresponds to the intestinal microflora.

An increase in intraductal pressure leads to bilivenous reflux of bacteria and endotoxin into the central circulation, causing biliary sepsis.

The main organs affected by the development of cholangitis are the cardiovascular system (microcirculation disorders), kidneys (insufficiency due to hypovolemia), liver and lungs. Endotoxemia in cholangitis leads to the rapid development of secondary immunodeficiency and disseminated intravascular coagulation syndrome. Septic shock develops in 10–30% of patients with obstructive purulent cholangitis.

The most widespread classification of cholangitis according to the clinical course (E.I. Galperin, 1977): acute form - Reynolds pentad, signs of a systemic reaction, septic shock; acute relapsing form - episodes of exacerbations alternate with periods of clinical remission; chronic form - the clinic is nonspecific (weakness, fatigue, subfebrile condition, slight jaundice). It is customary to divide cholangitis depending on the morphological changes in the ducts (catarrhal, phlegmonous, gangrenous, etc.), according to the degree of prevalence of the process (segmental intrahepatic and extrahepatic, common, total), according to the nature of the microflora (aerobic, anaerobic, mixed), by the nature of complications (without purulent complications, with liver abscesses, with systemic inflammatory response syndrome, with sepsis, with severe sepsis, septic shock).

Clinic of cholangitis: pain syndrome (right hypochondrium), Charcot's triad, Reynolds' pentad, the development of multiple organ failure and DIC is possible.

Laboratory studies: leukocytosis, cholestasis and cytolysis syndromes (increased bilirubin, transaminases, alkaline phosphatase, γ-glutamyl transferase).

It is necessary to perform blood cultures, determine indicators of hemostasis and kidney function.

Instrumental methods: ultrasound, MRI, ERCP, ChChPKh.

Basic principles of cholangitis treatment

Timely biliary decompression and restoration of biliary tract patency.

Carrying out intensive therapy aimed at reducing intoxication, reducing the manifestations of multiple organ failure, and stabilizing the patient's condition.

Timely adequate antibiotic therapy.

Biliary decompression can be performed using EPST (papillosphykterotomy, removal of calculi with a Dormia basket, placement of a stent, nasobiliary drainage) or PPHS. After restoration of bile flow, resolution of jaundice and intoxication, the patient undergoes open or laparoscopic cholecystectomy with correction of the pathology of the bile ducts.

It is also possible to perform laparoscopic cholecystectomy with revision of the biliary tract, choledochoscopy, removal of stones.

If minimally invasive decompression is not possible (large stones that cannot be removed), a traditional open operation, choledochotomy, restoration of bile outflow, external drainage of the bile ducts, followed by a planned cholecystectomy, is performed.

The choice of tactics depends on the patient's condition and the severity of cholangitis and the severity of endotoxemia.

Antibacterial therapy for acute cholangitis is prescribed upon admission, the choice of the drug is carried out empirically, further correction is possible taking into account the microflora. The main causative agents of cholangitis are gram-negative intestinal flora (E. coli and Klebsiella) and anaerobes (bacteroids). Taking into account the ability of antibiotic accumulation in bile and minimal hepatotoxicity, the use of inhibitor-protected penicillins and cephalosporins, ureidopenicillins, III-IV generation cephalosporins, fluoroquinolones and carbapenems is considered optimal. It is also rational to use metronidazole.

All patients with moderate and severe purulent intoxication are shown targeted detoxification. The most common methods are plasmapheresis (removal of endotoxin, cytokines, circulating immune complexes) and enterosorption (binding of endotoxin in the intestine, limiting its penetration into the portal circulation). It is possible to use hemosorption, xenospleen, etc. Research is underway to develop specific methods of detoxification, in particular, the use of human antiserum to endotoxin, endotoxin antagonists - polymyxin B, lactulose.

Mirizzi syndrome

The Argentine surgeon P. Mirizzi in 1948 first described the narrowing of the common hepatic duct, as well as the fistula between the gallbladder and the extrahepatic bile duct.

It is customary to distinguish between two forms of Mirizzi's syndrome: acute and chronic. The first form is most often manifested by a narrowing of the lumen of hepaticocholedochus, the second is characterized by the presence of a fistula between the gallbladder and the extrahepatic bile duct.

Pathogenesis

Against the background of acute calculous cholecystitis, compression of the extrahepatic bile ducts occurs with a calculus located in Hartmann's pocket (clinically - acute calculous cholecystitis and obstructive jaundice). During conservative treatment, the acute process may be resolved, but compression and inflammation around the hepaticocholedochus lead to the formation of a narrowing of the latter (stricture). Over time, the walls of the bile duct and the gallbladder come closer and under the influence of calculi between them there is a message (vesicocholedochal fistula), as a rule, at this stage the stricture is eliminated. Through this pathological formation, calculi from the gallbladder exit into the choledoch (rider bladder).

Diagnostics

The clinical manifestations of Mirizzi syndrome depend on the form of the disease. Patients with an acute form present complaints characteristic of acute calculous cholecystitis complicated by obstructive jaundice; the duration of the disease is usually short, choledocholithiasis occurs infrequently. The chronic form of the syndrome is characterized by a long course of cholelithiasis with exacerbations, choledocholithiasis, obstructive jaundice.

The main diagnostic method is ERCP.

Acute form of Mirizzi syndrome (X-ray signs of stricture)

Expansion of the bile ducts above the narrowing.

Symptoms of "breakage" of contrasting ducts.

Deviation of the deformed part of the duct.

Absence of calculi near the constriction zone.

Limited, not exceeding 1 cm deformation.

Chronic form of Mirizzi's syndrome (cholecystocholedochal fistula)

Contrasting of the gallbladder through the pathological fistula with hepaticocholedochus.

No enhancement of the cystic duct.

Deformation of the gallbladder.

Choledocholithiasis, stenosis of the major duodenal papilla.

The most dangerous manifestations of Mirizzi's syndrome, which pose a threat to the patient's life, are obstructive jaundice and acute cholecystitis.

The choice of the method of operation depends on the intraoperative picture, the data of intraoperative cholangiography. In the 1st form, cholecystectomy and drainage of the bile ducts (prevention of stricture progression) according to Kehr are most often performed. If an irreversible narrowing of the bile ducts is detected, hepaticojejunostomy may be performed.

If a cholecystocholedochal fistula is detected, it is possible to perform subtotal cholecystectomy or resection of the gallbladder with closure of the defect in the fistula zone and drainage of the hepaticocholedochus according to Ker. In case of significant destruction of the wall of the extrahepatic ducts, the operation of choice is hepaticojejunostomy.

Biliary fistulas

A biliary fistula is a persistent, constant or intermittent, complete or partial secretion of bile outward (external biliary fistula), into hollow organs (internal biliary fistula), bypassing its natural path to the intestine in whole or in part (Kalchenko I.I., 1966).

External biliary fistulas can be formed due to the inflammatory process in the gallbladder and the breakthrough of the abscess outward through all layers of the abdominal wall; after cholecystostomy and cholecystectomy in the presence of an obstruction in the terminal part of the choledochus (choledocholithiasis, stenosis of the BSDK, pancreatitis), with damage to the bile ducts during cholecystectomy and resection of the stomach.

When a biliary fistula is detected, it is necessary to clarify its type (complete or incomplete), the causes of formation, the condition of the bile ducts.

Diagnostics: fistula probing, fistulocholangiography, ERCP.

Treatment. In the presence of spontaneous biliary fistula due to perforation of the gallbladder and breakthrough of the abscess, a radical operation is indicated - cholecystectomy after sanitation of the fistula and abscess cavity.

With fistulas caused by biliary hypertension, it is necessary to perform EPST and remove stones from the ducts.

Treatment of bile duct injuries and their complications (external bile fistula, post-traumatic stricture, obstructive jaundice, cholangitis) is currently a serious medical and social problem. These patients are indicated for reconstructive biliodigestive surgery (hepaticojejunoanastomosis on the Roux-enabled loop), in some situations, the placement of a biliary plastic stent.

Internal bile fistulas. The main reason is the long course of calculous cholecystitis. The inflamed gallbladder is soldered to a portion of the intestine (usually the duodenum, less often the colon), then a fistula is formed. A biliary fistula can also form as a result of penetration into the gallbladder or duct of a gastric and duodenal ulcer, as well as a colon ulcer in ulcerative colitis or Crohn's disease. The most common are biliodigestive fistulas, rare anatomical variants are cholecystohepatic, biliovasal, biliopericardial and other fistulas.

Clinic. Recognition of internal biliary fistulas presents significant clinical and radiological difficulties. Symptoms that make it possible to suspect the presence of this complication include: 1) a sharp decrease and rapid disappearance of a previously determined infiltrate in the right hypochondrium or a decrease in the size of the gallbladder, especially if loose stools mixed with blood and pus appear at the same time; 2) sudden disappearance of pain syndrome, high temperature and reduction of jaundice; 3) development of signs of intestinal obstruction and discharge of gallstones with feces more than 1 cm; 4) signs of persistent, flowing without intense jaundice, cholangitis.

Fistulas can be asymptomatic and close after the stone passes into the intestine, in which case they are diagnosed during surgery.

Cholecystocolic fistulas can be manifested by severe cholangitis due to the reflux of intestinal contents. The entry of bile acids into the colon causes diarrhea and weight loss.

Diagnostics. Contrasting of the biliary tract is possible with oral administration of contrast (cholecystoduodenal fistula) or with barium enema (cholecystocolic). The method of choice is ERCP.

Surgical treatment: cholecystectomy with mandatory revision of the bile ducts, closure of the defect in the intestinal wall.

Gallstone obstruction

A gallstone with a diameter of more than 2.5 cm, which has entered the intestine through the fistula, can cause acute intestinal obstruction. Obturation usually occurs in the ileum, but cases of acute intestinal obstruction caused by a gallstone at the level of the duodenum, sigmoid, and rectum have been described.

Older women with a history of chronic calculous cholecystitis suffer more often. Clinic: paroxysmal pain, nausea, vomiting, bloating, gas and stool failure. Diagnosis is established on the basis of the data of the survey radiography of the abdominal cavity and ultrasound. With the failure of conservative treatment, signs of obstructive intestinal obstruction, it is indicated surgical intervention. The stone is brought down into the rectum and removed; with fixed stones, enterotomy is necessary.

The decision to perform cholecystectomy and close the biliary fistula at the same time is taken individually, depending on the patient's condition, surgical findings and surgeon's qualifications, since the elimination of the fistula during surgery for gallstone intestinal obstruction significantly increases the risk of surgical intervention in elderly and senile patients.

gallbladder cancer

FROM leaves from 1–7% of all malignant neoplasms, in the group of patients with biliopancretoduodenal localization - 10–14%. Histologically, adenocarcinoma is detected in 80% of cases.

The frequency of the combination of gallbladder cancer with cholelithiasis reaches, according to a number of authors, 75–90%, increasing in proportion to the duration of the cholelithiasis.

Precancerous diseases are also considered benign tumors of the gallbladder, they are divided into epithelial (papillomas, adenomas), non-epithelial (fibromas, myomas) and mixed (myxomas, adenomyomas, etc.). Papillomas and adenomas are the most common, malignancy is more common in formations more than 1.5 cm in diameter, the frequency of malignancy is 10–33%.

Classification. The International classification of gallbladder cancer according to TNM criteria is used, which takes into account the location and extent of the primary tumor, the presence or absence of metastases in regional lymph nodes, the presence or absence of distant metastases.

Primary tumor (T)

TX - Primary tumor cannot be assessed.

T0 - there are no signs of a primary tumor.

Tis - intraepithelial cancer without spread to the submucosal layer.

T1 - the tumor spreads in the mucous (T1a) or muscle (T1b) layers.

T2 - the tumor extends to the perimuscular connective tissue, but does not germinate the serosa or liver tissue.

T3 - the tumor grows into the serous membrane or spreads to the liver to a depth of 2 cm, or grows into one of the surrounding organs.

T4 - the tumor grows into the liver to a depth of more than 2 cm and / or into two or more neighboring organs.

Regional lymph nodes (N)

NX - regional lymph nodes cannot be assessed.

N0 - no signs of damage to the lymph nodes.

N1 - metastases in the lymph nodes located near the cystic and common bile duct and / or the gate of the liver.

N2 - metastases in the lymph nodes located near the head of the pancreas, duodenum, portal vein, celiac and / or superior mesenteric artery.

Distant metastases (M)

Mx - the presence of distant metastases cannot be assessed.

M0 - no distant metastases.

M1 - there are distant metastases.

Diagnostics

Gallbladder cancer is characterized by the absence of pathognomonic clinical signs and significant polymorphism of symptoms.

Clinical forms of gallbladder cancer (Aliev M.A., 1986)

Pseudocholithiasis- there are complaints and symptoms characteristic of chronic, less often acute calculous cholecystitis.

Tumor- the presence of a tumor in the right hypochondrium or a typical syndrome of "small signs".

icteric - The main symptom is obstructive jaundice.

Dyspeptic- the patient's doctor complains of nausea, vomiting, stool disorders.

Septic - persistent fever, sometimes hectic fever.

metastatic("silent") - initially metastases are detected in the liver and other organs.

Cancer symptoms can be masked by complications of cholelithiasis or the tumor itself - acute cholecystitis, cholangitis, liver abscesses, intestinal obstruction, bleeding during tumor growth.

Differential Diagnosis gallbladder cancer is carried out with chronic cholecystitis, benign tumors of the gallbladder, tumors of the hepatobiliopancreatoduodenal zone.

Before surgery, an accurate diagnosis can be established in 10–45% of cases.

instrumentaldiagnostics

ultrasound. During the study, thickening of the gallbladder wall and the presence of tissue masses associated with the gallbladder can be detected. The use of endosonography increases the sensitivity and specificity of the method.

CT is used mainly to determine the extent of the tumor process.

Laparoscopy - allows you to establish a diagnosis when the tumor grows into the wall of the organ, to carry out a targeted biopsy, to assess the prevalence of the process and to avoid a trial laparotomy.

If jaundice occurs, ERCP or PTCG may be used.

Laboratory diagnostics is of secondary importance and is based on the detection of anemia, cytolysis syndrome, cholestasis and liver failure.

It is possible to identify tumor markers of diseases of the liver and biliary tract - α-fetoprotein, carbohydrate antigen CA19-9.

Treatment

In 25-30% of patients with gallbladder cancer, when the diagnosis is established, radical treatment is impossible due to the prevalence of the process. Only 10–15% of initially diagnosed patients can be radically operated on.

The stage of the tumor determines the tactics and scope of the surgical benefit, and the age and general condition of the patient are also taken into account. Operations are traditionally divided into palliative and radical.

radical operations

Stage I (T1) - cholecystectomy with regional lymphadenectomy.

Stage II (T2) - cholecystectomy, resection of the gallbladder bed of at least 2-3 cm, lymphadenectomy.

Stage III (T3) - cholecystectomy, anatomical resection of IV-V segments of the liver, lymphadenectomy.

Palliative operations

Stage IV (T4) - operations are aimed at eliminating complications - restoration of bile outflow, resolution of intestinal obstruction, etc. (average life expectancy after palliative operations is 2–8 months).

Superradical operations have also been proposed in patients with stage IV of the process - removal of the gallbladder with right-sided hemihepatectomy and pancretoduodenal resection.

The options for chemotherapy, radiotherapy, and radiotherapy for gallbladder cancer are still limited.

Given the difficulties early diagnosis and unsatisfactory results of the treatment of gallbladder cancer, the main thing is the prevention of this formidable disease. Prevention consists in the timely detection and treatment of gallstone disease.

Tasks for independent work student

As a result self-study literature you need to know:

normal and topographic anatomy of the gallbladder, bile ducts, major duodenal papilla and pancreas;

etiology and pathogenesis of cholelithiasis and its main complications;

clinical picture of various forms of cholelithiasis;

basic laboratory methods for the diagnosis of cholelithiasis;

instrumental methods for diagnosing cholelithiasis, indications for their use;

therapeutic tactics in various forms of cholelithiasis.

To prepare for the lesson you need:

clearly orient in the goals and objectives of the upcoming lesson;

get acquainted with the content of the lecture "Cholelithiasis, acute and chronic calculous cholecystitis", read at the department;

familiarize yourself with the contents of these guidelines;

perform control tasks to check the results of self-training on the topic of the lesson.

Tests

Complications of cholelithiasis can be all pathological conditions, except for: a) acute pancreatitis; b) obstructive jaundice;
c) duodenostasis, d) obstructive small bowel obstruction; e) cholangitis.

For biliary colic, it is characteristic: 1) intense pain in the right hypochondrium; 2) irradiation of pain in the right shoulder blade; 3) Shchetkin-Blumberg symptom in the right hypochondrium; 4) Ortner's symptom; 5) heat. Choose the correct combination of answers: a) 1, 2, 4; b) 2, 3, 4; c) 4, 5; d) 3, 4; e) 2, 3, 5.

The clinic of acute cholangitis is usually characterized by: 1) hectic temperature; 2) pain in the right hypochondrium; 3) jaundice; 4) girdle pain; 5) bloating and indomitable vomiting. Choose the correct combination of answers: a) 1, 2, 4; b) 1, 2, 3; c) 3, 4, 5; d) 4, 5; e) 1, 4, 5.

For the diagnosis of choledocholithiasis, it is most advisable to use: 1) transabdominal ultrasound scanning; 2) intravenous cholegraphy; 3) ERCP; 4) duodenal sounding; 5) survey radiography of the abdominal cavity. Choose the best combination of answers: a) 1, 2;
b) 1, 2, 3; c) 1, 3; d) 3, 4; e) 2, 4, 5.

The most substantiated theories of stone formation in the gallbladder are: 1) infectious; 2) the theory of stagnation in the gallbladder; 3) metabolic disorders; 4) allergic; 5) the theory of "protective" colloids. Choose the best combination of answers: a) 1, 2; b) 1, 2, 3; c) 1, 3; d) 3, 4; e) 2, 4, 5.

The optimal method for diagnosing chronic calculous cholecystitis: a) ERCP; b) laparoscopy; c) ultrasonography; d) spiral CT;
e) duodenal sounding.

Acute obstructive cholangitis is manifested by: 1) jaundice; 2) chills; 3) an increase in the level of alkaline phosphatase in the blood; 4) leukocytosis;
5) an increase in the liver. Correct answer: a) 1, 2, 3, 5; b) 1, 2, 3, 4; c) 1, 2, 4, 5; d) everything is correct; d) everything is wrong.

Indications for intraoperative cholangiography: 1) detection of calculi in the choledochus during palpation; 2) suspicion of cicatricial narrowing of the large duodenal papilla; 3) the presence of jaundice before surgery; 4) an increase in the diameter of the common bile duct; 5) jaundice at the time of surgery. Correct answer: a) 1, 2, 3, 4; b) 1, 3, 4; c) 3, 4; d) 1, 3, 4, 5; e) All answers are correct.

Treatment indicated for a patient with an attack of biliary colic caused by gallstones: a) emergency surgery; b) conservative treatment; c) urgent operation after stopping the attack; d) antienzymatic therapy; e) laparoscopic cholecystostomy.

The characteristic signs of obstructive jaundice against the background of choledocholithiasis will be: 1) hyperbilirubinemia; 2) leukopenia; 3) bilirubinuria;
4) positive stool reaction to stercobilin; 5) high level of alkaline phosphatase in the blood. Correct answers: a) 1, 3, 5; b) 2, 3, 5; c) 3, 4, 5; d) everything is correct; d) everything is wrong.

To make a diagnosis of obstructive jaundice and find out its cause, everything is used, except: a) AST and ALT studies; b) infusion holography; c) laparoscopy; d) ERCP; e) percutaneous transhepatic cholangiography.

When stones are found in the gallbladder, cholecystectomy is indicated in the following cases: a) in all cases; b) with a latent form of the disease; c) with a decrease in working capacity; d) the operation is contraindicated in elderly and senile patients; e) the operation is contraindicated in patients under 18 years of age.

For jaundice due to choledocholithiasis is not typical: a) bilirubinemia; b) urobilinuria; c) increased alkaline phosphatase in the blood; d) normal activity of AST and ALT; e) absence of stercobilin in feces.

A complication of cholelithiasis requiring emergency surgical intervention is: a) diffuse peritonitis; b) cicatricial stricture of the common bile duct; c) choledocholithiasis; d) enterovesical fistula; e) jaundice.

With what disease is it most often necessary to differentiate chronic cholecystitis: a) stomach cancer; b) duodenal ulcer; c) chronic gastritis; d) peptic ulcer of the stomach;
e) chronic pancreatitis?

Cholecystectomy for cholelithiasis is indicated when: 1) there is no filling of the gallbladder on the cholangiogram; 2) stones that cause repeated colic; 3) gallbladder stones that cause dyspeptic symptoms; 4) stones, often leading to recurrences of cholecystitis; 5) more than five stones on the cholecystogram. Correct will be: a) 1, 2; b) 4; at 12; d) 3, 4, 5 everything is right.

Intraoperative methods for examining the extrahepatic biliary tract do not include: a) palpation of the common bile duct; b) cholangiomanometry;
c) intravenous cholegraphy; d) choledochoscopy; e) intraoperative cholangiography.

For hepatic colic is not typical: a) pain in the right hypochondrium with irradiation to the back; b) phrenicus symptom; c) Murphy's symptom; d) pronounced muscle tension and pain in the right hypochondrium; e) Ortner's symptom.

Which of the complications of cholelithiasis requires urgent surgical intervention: 1) acute catarrhal cholecystitis; 2) cholecystopancreatitis; 3) choledocholithiasis; 4) mechanical jaundice; 5) biliary colic? Choose the best combination of answers: a) 1, 4, 5; b) 2, 4; c) 1, 2, 3, 4;
d) everything is correct; d) everything is wrong.

A 50-year-old patient six months after cholecystectomy performed for chronic calculous cholecystitis again began to experience pain in the right hypochondrium, periodically accompanied by yellowing of the sclera. Ultrasound examination of the abdominal cavity did not reveal any obvious pathology of the extrahepatic biliary tract. Which of the following methods is the most informative for diagnosis in this case: a) infusion cholegraphy; b) oral cholecystography:
c) ERCP; d) liver scan; e) computed tomography?

Which of the following signs is the most reliable in the diagnosis of cholelithiasis: a) positive symptom of Courvoisier; b) a positive symptom of Murphy; c) the presence of ultrasound signs of stones; d) increase in serum bilirubin above 30 µm/l; e) high levels of ACT and ALT?

Obstructive jaundice is characterized by signs: 1) increased direct serum bilirubin; 2) increase in indirect bilirubin in blood serum; 3) bilirubinuria; 4) hypercholesterolemia; 5) increase in stercobilin in feces. Choose the correct combination of answers: a) 1, 3, 5; b) 1, 3, 4; c) 2, 3, 4; d) 2, 3, 4, 5; e) 2, 3.

Gallstone disease is dangerous: 1) the development of cirrhosis of the liver;
2) cancerous degeneration of the gallbladder; 3) secondary pancreatitis;
4) development of destructive cholecystitis; 5) possible obstructive jaundice. Correct will be: a) everything is correct; b) 3, 4, 5; c) 1.5; d) 1, 3, 4, 5; e) 2, 3, 4, 5.

The formation of cholesterol stones in the gallbladder contributes to: 1) pregnancy; 2) metabolic disorders; 3) taking aspirin; 4) age; 5) gender; 6) constitution; 7) increased amount of bile acids. Correct will be: a) 1, 2, 3, 4, 7; b) 1, 2, 3, 4, 6, 7; c) everything is correct; d) 1, 2, 4, 5, 6; 7;
e) 2, 3, 4, 5, 7.

In acute cholecystitis, a differential diagnosis should be made with: 1) acute pancreatitis; 2) perforated duodenal ulcer; 3) acute appendicitis; 4) right-sided pleuropneumonia;
5) chronic pancreatitis in the acute stage. Choose the best combination of answers: a) 1, 2, 4; b) 1, 2, 3; c) 2, 3, 5; d) 3, 4, 5; d) everything is correct

An accurate diagnosis of acute calculous cholecystitis can be made on the basis of: 1) patient complaints; 2) anamnesis; 3) ultrasound scanning of the gallbladder and pancreas; 4) infusion cholangiography; 5) retrograde cholangiopancreatography. Correct answers: a) 1, 2, 3; b) 2, 3, 4; c) 3, 4, 5; d) 2, 4, 5; e) 4, 5.

The complications of acute calculous cholecystitis include everything except: a) varicose veins of the esophagus; b) obstructive jaundice; c) cholangitis; d) subhepatic abscess; e) peritonitis.

A patient with gangrenous cholecystitis is shown: a) emergency surgery; b) delayed operation; c) conservative treatment; d) surgery in the absence of the effect of conservative therapy; e) the decision depends on the age of the patient.

What is the advantage of performing cholecystectomy from the neck: 1) conditions are created for bloodless removal of the gallbladder; 2) the path of entry of purulent bile into the choledoch is interrupted; 3) it is possible to avoid the migration of stones from the bladder into the choledoch; 4) allows to refrain from choledochotomy; 5) eliminates the need for intraoperative cholangiography? Correct answers: a) 1, 2, 4; b) 1, 3, 4; c) 2, 4, 5; d) 1, 2, 3; e) 1, 2, 5.

Acute calculous cholecystitis usually develops due to:
1) entry into the gallbladder of infected bile; 2) stagnation of bile in the gallbladder; 3) the presence of stones in the gallbladder; 4) thrombosis of the cystic artery; 5) obstruction of the cystic duct. Correct answer: a) 1, 2; b) 1, 2, 3, 4; c) 2, 4, 5; d) 3, 4, 5; e) 4 and 5.

In acute destructive cholecystitis, cholecystostomy is indicated for: a) concomitant edematous pancreatitis; b) an elderly patient; c) in severe general condition of the patient; d) the presence of an infiltrate in the neck of the gallbladder; e) concomitant cholangitis.

Absolute contraindication for laparoscopic cholecystectomy: 1) intrahepatic location of the gallbladder; 2) elderly and senile age of the patient; 3) acute calculous cholecystitis; 4) the presence of choledocholithiasis; 5) reasonable suspicion of gallbladder cancer; 6) acute pancreatitis; 7) late pregnancy. Correct answer: a) everything is correct; b) everything is wrong; c) 1, 5, 7; d) 2, 3, 4, 5, 6; e) 5, 6, 7.

Answers

1-in; 2-a; 3-b; 4-in; 5 B; 6-in; 7-d; 8-d; 9-b; 10-a; 11-b; 12-a; 13-b; 14-a; 15-b; 16-d; 17-in; 18-g; 19-d; 20-in; 21-in; 22-b; 23-d; 24-d; 25-d; 26-a; 27-a; 28-g; 29-d; 30-d; 31-in; 32-d.

Situational tasks

1. A 30-year-old patient consulted a polyclinic therapist complaining of recurring pain in the right hypochondrium. Pain disappears on its own after 5–20 minutes and is not accompanied by fever and dyspeptic symptoms. At the time of examination, there is no pain, the abdomen is soft, painless. The doctor referred the patient for an ultrasound scan (see figure). Your presumptive diagnosis. Recommend treatment.

2. A 58-year-old patient was delivered on the third day from the onset of pain in the right hypochondrium, the temperature rose to 38 degrees. Previously, there were repeated attacks of such pain, which lasted for 5-7 days. The general condition is satisfactory. The abdomen is tense and painful in the right hypochondrium, where a painful infiltrate up to 10 cm in diameter is palpated. There are no symptoms of peritoneal irritation. Ultrasound: gallbladder 120 x 50 mm, 15 mm calculus in the neck area, does not move when the body position changes, the gallbladder wall is up to 8 mm. Make a diagnosis. Recommendations for treatment.

3. A 60-year-old patient was delivered with severe jaundice that began after an attack of severe pain in the right hypochondrium. Suffering from gallstone disease for three years. Attacks of pain occur 3-4 times a year after a violation of the diet. There was no jaundice and temperature during attacks before. The sclera and skin are icteric, the abdomen is soft, moderately painful in the right hypochondrium. Ultrasound - gallbladder 7520 mm, wall 2 mm, in the lumen there are many stones up to 8 mm; choledochus up to 16 mm, extra- and intrahepatic passages are expanded. FGDS - there is no bile in the duodenum, the major duodenal papilla is not changed. What complications of cholelithiasis developed in the patient? What additional diagnostic methods should be used? Treatment.

4. A 45-year-old patient periodically complains of pain in the right hypochondrium, not associated with eating. Ultrasound examination repeatedly revealed polyps of the gallbladder up to 5 mm, no stones were found. What is your tactic?

5. A 58-year-old patient was admitted to the clinic on the second day of the disease with complaints of pain in the right hypochondrium, nausea, vomiting of bile. The abdomen is tense and painful in the right hypochondrium, positive symptoms of Murphy, Ortner, Mussi-Georgievsky. Leukocytosis - 1510 9 / l. Ultrasound picture of acute calculous cholecystitis. After the conservative treatment, within 24 hours, improvement is noted, slight pain in the right hypochondrium persists, leukocytosis - 910 9 /l. What is your treatment strategy?

6. A 48-year-old patient was admitted with a clinical picture of acute cholecystitis. The patient was prescribed conservative treatment. Three hours after admission, abdominal pain intensified, a positive symptom of Shchetkin-Blumberg in the right hypochondrium and right iliac region. What complication has developed in the patient? What is the treatment strategy?

7. A 57-year-old patient was admitted with moderate pain in the right hypochondrium, radiating to the shoulder blade. She has a history of chronic calculous cholecystitis. There were no changes in the parameters of the general blood test. There is no jaundice. On palpation, an enlarged, slightly painful gallbladder is determined. The temperature is normal. What is your diagnosis? Medical tactics.

8. A 56-year-old patient, who has been suffering from cholelithiasis for a long time, was admitted on the 3rd day from the onset of an exacerbation of the disease. Conducting complex conservative therapy did not lead to an improvement in the patient's condition. During the observation, there was a significant bloating, cramping nature of pain, repeated vomiting with an admixture of bile. Abdominal x-ray: pneumatosis of the small intestine, aerocholia. Your proposed diagnosis, treatment tactics.

9. An 80-year-old patient suffers from frequent attacks of calculous cholecystitis with severe pain. She has a history of two myocardial infarctions and arterial hypertension. Two months ago I suffered a cerebral infarction. There are no signs of peritonitis. Which treatment method should be preferred?

10. A 55-year-old patient who underwent cholecystectomy 2 years ago was admitted with a clinical picture of obstructive jaundice. When performing ERCP - signs of choledocholithiasis. What method of treatment is indicated for the patient?

11. A patient who underwent endoscopic papillosphincterotomy has intense pain in the epigastric region with irradiation to the lower back, repeated vomiting, muscle tension in the anterior abdominal wall. Pronounced leukocytosis and increased serum amylase. What is your diagnosis? What is the treatment strategy?

Answers to situational tasks

1. Cholelithiasis, attacks of hepatic colic. Elective laparoscopic cholecystectomy was recommended.

2. Acute phlegmonous calculous obstructive cholecystitis. Urgent surgical treatment is indicated - cholecystectomy, in the presence of contraindications - two-stage treatment (imposition of cholecystostomy under local anesthesia).

3. Choledocholithiasis, obstructive jaundice. ERCP, endosonography. Endoscopic papillosphincterotomy, extraction of calculi, after resolution of jaundice - planned cholecystectomy.

4. The risk of developing gallbladder cancer and the presence of clinical manifestations of polyps - indications for surgical treatment - laparoscopic cholecystectomy.

5. The patient is shown surgical treatment - delayed cholecystectomy after additional examination.

6. The patient developed perforation of the gallbladder with the development of widespread peritonitis. An emergency operation is indicated - cholecystectomy, sanitation and drainage of the abdominal cavity, according to indications - setting tampons and external drainage of the biliary tract.

7. The patient, probably, has hydrocele of the gallbladder, planned surgical treatment is indicated - cholecystectomy.

8. The patient probably has acute gallstone intestinal obstruction, if conservative treatment is ineffective, emergency surgery is indicated - laparotomy, enterotomy, removal of the stone.

9. The patient is shown conservative therapy, in case of ineffectiveness - cholecystostomy.

10. Performing endoscopic papillosphykterotomy, sanitation of hepaticocholedochus using Dormia's basket, Fogarty's catheter.

11. The patient developed acute pancreatitis, complex conservative treatment is indicated.

Main literature

Surgical Diseases: Textbook / Ed. M.I. Cousin. - 3rd ed. revised and additional - M: Medicine, 2002. - 784 p.

additional literature

Grishin I.N.. Cholecystectomy: A practical guide. – Mn.: Vysh. school, 1989. - 198 p.

gallstone disease / S.A. Dadvani, P.S. Vetshev, A.M. Shulutko, M.I. Prudkov; Moscow honey. acad. them. THEM. Sechenov, Ural. state honey. acad. - M .: Publishing house. house Vidar - M, 2000. - 139 p.

Korolev B.A., Pikovsky D.L.. Emergency surgery of the biliary tract. - M.: Medicine, 1990. - 240 p.

of non-communicable diseases in the outpatient clinic ... BelMAPO, 2004. - 42 p. Leonovich, S. I. gallstonedisease. Spicy and chroniccalculouscholecystitis: method. recommendations / S. I. Leonovich, A. ...

1. Dissertation abstract

   ... sharpcalculouscholecystitis; FLOOR at chroniccalculouscholecystitis sharpcholecystitis to the number of operations chroniccholecystitis... activity at cholelithiasisdisease and sharpcholecystitis like way...

2. VOLGOGRAD RED BANNER ORDER OF LABOR BYKOV Aleksandr Viktorovich MODERN APPROACHES TO THE DIAGNOSIS AND SURGICAL TREATMENT OF Cholelithiasis 14

   Dissertation abstract

   ... sharpcalculouscholecystitis; FLOOR at chroniccalculouscholecystitis; the ratio of the number of operations at sharpcholecystitis to the number of operations chroniccholecystitis... activity at cholelithiasisdisease and sharpcholecystitis like way...

3. Clinical history

   Document

   17 Diagnosis of the referring institution: gallstonedisease, chroniccalculouscholecystitis. Surgical operations: 287 Cholecystectomy... chronic. At sharpcholecystitis usually the onset of the attack is not as violent as with. cholelithiasisdisease ...